BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends in Cell Biology 2006;16:79-87. [DOI: 10.1016/j.tcb.2005.12.005] [Cited by in Crossref: 463] [Cited by in F6Publishing: 429] [Article Influence: 28.9] [Reference Citation Analysis]
Number Citing Articles
1 Hahnel A, Wichmann H, Kappler M, Kotzsch M, Vordermark D, Taubert H, Bache M. Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells. Radiat Oncol 2010;5:82. [PMID: 20849637 DOI: 10.1186/1748-717X-5-82] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
2 Niino M, Kikuchi S. Osteopontin and multiple sclerosis: An update: OPN and MS. Clinical and Experimental Neuroimmunology 2011;2:33-40. [DOI: 10.1111/j.1759-1961.2011.00019.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Caswell PT, Chan M, Lindsay AJ, McCaffrey MW, Boettiger D, Norman JC. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol 2008;183:143-55. [PMID: 18838556 DOI: 10.1083/jcb.200804140] [Cited by in Crossref: 287] [Cited by in F6Publishing: 269] [Article Influence: 20.5] [Reference Citation Analysis]
4 Rocha GA, de Melo FF, Cabral MMDA, de Brito BB, da Silva FAF, Queiroz DMM. Interleukin-27 is abrogated in gastric cancer, but highly expressed in other Helicobacter pylori-associated gastroduodenal diseases. Helicobacter. 2020;25:e12667. [PMID: 31702083 DOI: 10.1111/hel.12667] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, Eguchi S, Gu J, Ma D. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis 2018;9:356. [PMID: 29500465 DOI: 10.1038/s41419-018-0391-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 23.5] [Reference Citation Analysis]
6 Staibano S, Merolla F, Testa D, Iovine R, Mascolo M, Guarino V, Castellone MD, Di Benedetto M, Galli V, Motta S. OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br J Cancer. 2007;97:1545-1551. [PMID: 17987038 DOI: 10.1038/sj.bjc.6604070] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
7 Kunii Y, Niwa S, Hagiwara Y, Maeda M, Seitoh T, Suzuki T. The immunohistochemical expression profile of osteopontin in normal human tissues using two site-specific antibodies reveals a wide distribution of positive cells and extensive expression in the central and peripheral nervous systems. Med Mol Morphol 2009;42:155-61. [PMID: 19784742 DOI: 10.1007/s00795-009-0459-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
8 Iqbal J, Sarkar-Dutta M, McRae S, Ramachandran A, Kumar B, Waris G. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44. J Virol 2018;92:e02116-17. [PMID: 29669827 DOI: 10.1128/JVI.02116-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Li N, Song J, Zhu G, Shi X, Wang Y. Alendronate conjugated nanoparticles for calcification targeting. Colloids and Surfaces B: Biointerfaces 2016;142:344-50. [DOI: 10.1016/j.colsurfb.2016.03.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
10 Verheul C, Kleijn A, Lamfers MLM. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system. Handb Clin Neurol 2017;146:139-69. [PMID: 29110768 DOI: 10.1016/B978-0-12-804279-3.00010-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Song JY, Lee JK, Lee NW, Yeom BW, Kim SH, Lee KW. Osteopontin expression correlates with invasiveness in cervical cancer. Aust N Z J Obstet Gynaecol 2009;49:434-8. [PMID: 19694703 DOI: 10.1111/j.1479-828X.2009.01027.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
12 Liguori M, Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma. Cancers (Basel) 2011;3:3740-61. [PMID: 24213109 DOI: 10.3390/cancers3043740] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
13 Walker C, Nguyen TM, Jessel S, Alvero AB, Silasi DA, Rutherford T, Draghici S, Mor G. Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer. Cancers (Basel) 2021;13:325. [PMID: 33477343 DOI: 10.3390/cancers13020325] [Reference Citation Analysis]
14 Shi L, Wang X. Role of osteopontin in lung cancer evolution and heterogeneity. Semin Cell Dev Biol 2017;64:40-7. [PMID: 27578008 DOI: 10.1016/j.semcdb.2016.08.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
15 Lv Y, Jin Y, Zhou Y, Jin J, Ma Z, Ren Z. Deep sequencing of transcriptome profiling of GSTM2 knock-down in swine testis cells. Sci Rep 2016;6:38254. [PMID: 27905550 DOI: 10.1038/srep38254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis 2019;36:171-98. [PMID: 30972526 DOI: 10.1007/s10585-019-09966-1] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 38.7] [Reference Citation Analysis]
17 Chan KK, Matchett KB, McEnhill PM, Dakir el H, McMullin MF, El-Tanani Y, Patterson L, Faheem A, Rudland PS, McCarron PA, El-Tanani M. Protein deregulation associated with breast cancer metastasis. Cytokine Growth Factor Rev 2015;26:415-23. [PMID: 26088937 DOI: 10.1016/j.cytogfr.2015.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Hsu LH, Hsu PC, Liao TL, Feng AC, Chu NM, Kao SH. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study. BMC Cancer 2016;16:463. [PMID: 27411914 DOI: 10.1186/s12885-016-2529-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lin AY, Chua MS, Choi YL, Yeh W, Kim YH, Azzi R, Adams GA, Sainani K, van de Rijn M, So SK. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker. PLoS One. 2011;6:e16636. [PMID: 21383983 DOI: 10.1371/journal.pone.0016636] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
20 Phillips RJ, Helbig KJ, Hoek KHVD, Seth D, Beard MR. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J Gastroenterol 2012; 18(26): 3389-3399 [PMID: 22807608 DOI: 10.3748/wjg.v18.i26.3389] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
21 Fardin P, Ognibene M, Vanni C, De Santanna A, Varesio L, Eva A. Induction of epithelial mesenchimal transition and vasculogenesis in the lenses of Dbl oncogene transgenic mice. PLoS One 2009;4:e7058. [PMID: 19759912 DOI: 10.1371/journal.pone.0007058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
22 He CY, Liang BB, Fan XY, Cao L, Chen R, Guo YJ, Zhao J. The dual role of osteopontin in acetaminophen hepatotoxicity. Acta Pharmacol Sin 2012;33:1004-12. [PMID: 22728710 DOI: 10.1038/aps.2012.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
23 Spyrou N, Avgerinos KI, Mantzoros CS, Dalamaga M. Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies. Curr Obes Rep 2018;7:260-75. [DOI: 10.1007/s13679-018-0318-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
24 Nam JS, Suchar AM, Kang MJ, Stuelten CH, Tang B, Michalowska AM, Fisher LW, Fedarko NS, Jain A, Pinkas J, Lonning S, Wakefield LM. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res 2006;66:6327-35. [PMID: 16778210 DOI: 10.1158/0008-5472.CAN-06-0068] [Cited by in Crossref: 67] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
25 Clemente N, Raineri D, Cappellano G, Boggio E, Favero F, Soluri MF, Dianzani C, Comi C, Dianzani U, Chiocchetti A. Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases. J Immunol Res 2016;2016:7675437. [PMID: 28097158 DOI: 10.1155/2016/7675437] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 9.7] [Reference Citation Analysis]
26 Lorenzen J, Krämer R, Kliem V, Bode-boeger SM, Veldink H, Haller H, Fliser D, Kielstein JT. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. European Journal of Clinical Investigation 2010;40:294-300. [DOI: 10.1111/j.1365-2362.2010.02271.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
27 Wang K, Holterman AX. Pathophysiologic role of hepatocyte nuclear factor 6. Cell Signal. 2012;24:9-16. [PMID: 21893194 DOI: 10.1016/j.cellsig.2011.08.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
28 Iqbal J, McRae S, Mai T, Banaudha K, Sarkar-Dutta M, Waris G. Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes. PLoS One 2014;9:e87464. [PMID: 24498111 DOI: 10.1371/journal.pone.0087464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
29 Rocco M, Malorni L, Cozzolino R, Palmieri G, Rozzo C, Manca A, Parente A, Chambery A. Proteomic Profiling of Human Melanoma Metastatic Cell Line Secretomes. J Proteome Res 2011;10:4703-14. [DOI: 10.1021/pr200511f] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
30 Klinthoopthamrong N, Chaikiawkeaw D, Phoolcharoen W, Rattanapisit K, Kaewpungsup P, Pavasant P, Hoven VP. Bacterial cellulose membrane conjugated with plant-derived osteopontin: Preparation and its potential for bone tissue regeneration. Int J Biol Macromol 2020;149:51-9. [PMID: 31981668 DOI: 10.1016/j.ijbiomac.2020.01.158] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
31 Zhu W, Guo L, Zhang B, Lou L, Lin Z, Zhu X, Ren N, Dong Q, Ye Q, Qin L. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection. Ann Surg Oncol. 2014;21:1304-1313. [PMID: 24366422 DOI: 10.1245/s10434-013-3445-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
32 Debucquoy A, Goethals L, Geboes K, Roels S, Mc Bride WH, Haustermans K. Molecular responses of rectal cancer to preoperative chemoradiation. Radiotherapy and Oncology 2006;80:172-7. [DOI: 10.1016/j.radonc.2006.07.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
33 Guiry EJ, Szpak P, Soto D. Quality control for modern bone collagen stable carbon and nitrogen isotope measurements. Methods Ecol Evol 2020;11:1049-60. [DOI: 10.1111/2041-210x.13433] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
34 Bellahcène A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer. 2008;8:212-226. [PMID: 18292776 DOI: 10.1038/nrc2345] [Cited by in Crossref: 305] [Cited by in F6Publishing: 291] [Article Influence: 21.8] [Reference Citation Analysis]
35 Banerjee S, Jha HC, Robertson ES. Regulation of the metastasis suppressor Nm23-H1 by tumor viruses. Naunyn Schmiedebergs Arch Pharmacol 2015;388:207-24. [PMID: 25199839 DOI: 10.1007/s00210-014-1043-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
36 Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich JT, Bunker KL, Cena LG, Sparrow MC, Sturgeon JL, Dinu CZ, Sargent LM. Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Part Fibre Toxicol 2014;11:6. [PMID: 24479647 DOI: 10.1186/1743-8977-11-6] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 13.5] [Reference Citation Analysis]
37 Kaleta B, Boguska A. Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells. Arch Immunol Ther Exp (Warsz) 2017;65:347-53. [PMID: 28210757 DOI: 10.1007/s00005-017-0455-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
38 Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Hölttä E. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9. Am J Pathol 2014;184:842-58. [PMID: 24412090 DOI: 10.1016/j.ajpath.2013.11.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
39 Poggio P, Branchetti E, Grau JB, Lai EK, Gorman RC, Gorman JH 3rd, Sacks MS, Bavaria JE, Ferrari G. Osteopontin-CD44v6 interaction mediates calcium deposition via phospho-Akt in valve interstitial cells from patients with noncalcified aortic valve sclerosis. Arterioscler Thromb Vasc Biol 2014;34:2086-94. [PMID: 25060796 DOI: 10.1161/ATVBAHA.113.303017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
40 O'Brien JH, Vanderlinden LA, Schedin PJ, Hansen KC. Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. J Proteome Res 2012;11:4894-905. [PMID: 22897585 DOI: 10.1021/pr3003744] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
41 New M, Van Acker T, Long JS, Sakamaki JI, Ryan KM, Tooze SA. Molecular Pathways Controlling Autophagy in Pancreatic Cancer. Front Oncol 2017;7:28. [PMID: 28316954 DOI: 10.3389/fonc.2017.00028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
42 Chen RX, Xia YH, Xue TC, Ye SL. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression. J Exp Clin Cancer Res 2010;29:172. [PMID: 21190594 DOI: 10.1186/1756-9966-29-172] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
43 Wang X, Chao L, Ma G, Chen L, Jin G, Hua M, Liu H, Ouyang A, Zhang X. Primary breast carcinoma: association of mammographic calcifications with osteopontin expression. Radiology 2010;254:69-78. [PMID: 20019131 DOI: 10.1148/radiol.2541090675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
44 Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer 2007;57:373-80. [PMID: 17513004 DOI: 10.1016/j.lungcan.2007.04.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
45 Sangar V, Funk CC, Kusebauch U, Campbell DS, Moritz RL, Price ND. Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells. Mol Cell Proteomics 2014;13:2618-31. [PMID: 24997998 DOI: 10.1074/mcp.M114.040428] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
46 Zhang H, Zhong J, Tu Y, Liu B, Chen Z, Luo Y, Tang Y, Xiao F. Integrated Bioinformatics Analysis Identifies Hub Genes Associated with the Pathogenesis and Prognosis of Esophageal Squamous Cell Carcinoma. Biomed Res Int. 2019;2019:2615921. [PMID: 31950035 DOI: 10.1155/2019/2615921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
47 van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC, van der Pluijm G. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis. Clin Exp Metastasis 2011;28:615-25. [PMID: 21647815 DOI: 10.1007/s10585-011-9395-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
48 Chaen T, Konno T, Egashira M, Bai R, Nomura N, Nomura S, Hirota Y, Sakurai T, Imakawa K. Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. PLoS One 2012;7:e48933. [PMID: 23152823 DOI: 10.1371/journal.pone.0048933] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
49 Selkirk SM, Morrow J, Barone TA, Hoffer A, Lock J, DeChant A, Mangla S, Plunkett RJ, Miller RH. Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal. J Neurooncol 2008;86:285-96. [PMID: 17928956 DOI: 10.1007/s11060-007-9477-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Huang X, Chen S, Shen Q, Yang L, Li B, Zhong L, Geng S, Du X, Li Y. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol 2010;3:44. [PMID: 21080944 DOI: 10.1186/1756-8722-3-44] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
51 Saika S, Shirai K, Yamanaka O, Miyazaki K, Okada Y, Kitano A, Flanders KC, Kon S, Uede T, Kao WW, Rittling SR, Denhardt DT, Ohnishi Y. Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium. Lab Invest 2007;87:130-8. [PMID: 17211411 DOI: 10.1038/labinvest.3700508] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
52 Jang T, Sathy B, Hsu Y, Merchant M, Recht B, Chang C, Recht L. A distinct phenotypic change in gliomas at the time of magnetic resonance imaging detection: Laboratory investigation. JNS 2008;108:782-90. [DOI: 10.3171/jns/2008/108/4/0782] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
53 Villanueva F, Araya H, Briceño P, Varela N, Stevenson A, Jerez S, Tempio F, Chnaiderman J, Perez C, Villarroel M, Concha E, Khani F, Thaler R, Salazar-Onfray F, Stein GS, van Wijnen AJ, Galindo M. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis. J Cell Physiol 2019;234:13659-79. [PMID: 30637720 DOI: 10.1002/jcp.28046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
54 Rattanapisit K, Abdulheem S, Chaikeawkaew D, Kubera A, Mason HS, Ma JK, Pavasant P, Phoolcharoen W. Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells. Sci Rep 2017;7:17358. [PMID: 29229947 DOI: 10.1038/s41598-017-17666-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
55 Moschos C, Porfiridis I, Psallidas I, Kollintza A, Stathopoulos GT, Papiris SA, Roussos C, Kalomenidis I. Osteopontin is upregulated in malignant and inflammatory pleural effusions. Respirology 2009;14:716-22. [PMID: 19476604 DOI: 10.1111/j.1440-1843.2009.01536.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
56 Xing S, Zheng X, Wei LQ, Song SJ, Liu D, Xue N, Liu XM, Wu MT, Zhong Q, Huang CM, Zeng MS, Liu WL. Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing. J Cancer. 2017;8:2346-2355. [PMID: 28819439 DOI: 10.7150/jca.19465] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zeng F, Zhang Y, Han X, Zeng M, Gao Y, Weng J. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns. Front Immunol 2020;11:609900. [PMID: 33574818 DOI: 10.3389/fimmu.2020.609900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ivanov SV, Ivanova AV, Goparaju CM, Chen Y, Beck A, Pass HI. Tumorigenic properties of alternative osteopontin isoforms in mesothelioma. Biochemical and Biophysical Research Communications 2009;382:514-8. [DOI: 10.1016/j.bbrc.2009.03.042] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
59 Zhao J, Lu B, Xu H, Tong X, Wu G, Zhang X, Liang A, Cong W, Dai J, Wang H. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology. 2008;48:265-275. [PMID: 18537194 DOI: 10.1002/hep.22280] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
60 Lin R, Wu S, Zhu D, Qin M, Liu X. Osteopontin induces atrial fibrosis by activating Akt/GSK-3β/β-catenin pathway and suppressing autophagy. Life Sci 2020;245:117328. [PMID: 31954162 DOI: 10.1016/j.lfs.2020.117328] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
61 Shevde LA, Das S, Clark DW, Samant RS. Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med. 2010;10:71-81. [PMID: 20205680 DOI: 10.2174/156652410791065381] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 7.9] [Reference Citation Analysis]
62 Fang D, Kitamura H. Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches. Int J Urol. 2018;25:7-17. [PMID: 28697535 DOI: 10.1111/iju.13404] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
63 Kim HJ, Lee HJ, Jun JI, Oh Y, Choi SG, Kim H, Chung CW, Kim IK, Park IS, Chae HJ. Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53. Proc Natl Acad Sci USA. 2009;106:15326-15331. [PMID: 19706414 DOI: 10.1073/pnas.0903704106] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
64 Song K, Liu N, Yang Y, Qiu X. Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262. Tumor Biol 2016;37:6493-9. [DOI: 10.1007/s13277-015-4530-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
65 Quaglia M, Chiocchetti A, Cena T, Musetti C, Monti S, Clemente N, Dianzani U, Magnani C, Stratta P. Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients. Clin Rheumatol 2014;33:1263-71. [PMID: 24820147 DOI: 10.1007/s10067-014-2665-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
66 Lee CY, Tien HF, Hou HA, Chou WC, Lin LI. Marrow osteopontin level as a prognostic factor in acute myeloid leukaemia. Br J Haematol 2008;141:736-9. [PMID: 18397342 DOI: 10.1111/j.1365-2141.2008.07082.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
67 Kiss T, Ecsedi S, Vizkeleti L, Koroknai V, Emri G, Kovács N, Adany R, Balazs M. The role of osteopontin expression in melanoma progression. Tumour Biol 2015;36:7841-7. [PMID: 25944164 DOI: 10.1007/s13277-015-3495-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
68 Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008;38:489-99. [DOI: 10.1002/eji.200737057] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
69 Mi T, Nie B, Zhang C, Zhou H. The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication. J Huazhong Univ Sci Technolog Med Sci 2011;31:602. [PMID: 22038347 DOI: 10.1007/s11596-011-0568-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
70 Thorat D, Sahu A, Behera R, Lohite K, Deshmukh S, Mane A, Karnik S, Doke S, Kundu GC. Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers. Oncol Lett 2013;6:1559-64. [PMID: 24260046 DOI: 10.3892/ol.2013.1600] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
71 Gan N, Zou S, Hang W, Yang D, Zhang X, Yin Y. Osteopontin is Critical for Hyperactive mTOR-Induced Tumorigenesis in Oral Squamous Cell Carcinoma. J Cancer 2017;8:1362-70. [PMID: 28638450 DOI: 10.7150/jca.18031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
72 Tilli TM, Mello KD, Ferreira LB, Matos AR, Accioly MT, Faria PA, Bellahcène A, Castronovo V, Gimba ER. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells. Prostate 2012;72:1688-99. [PMID: 22495819 DOI: 10.1002/pros.22523] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
73 Zendehdel E, Abdollahi E, Momtazi‐borojeni AA, Korani M, Alavizadeh SH, Sahebkar A. The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells. J Cell Biochem 2019;120:4739-47. [DOI: 10.1002/jcb.27757] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
74 Fu Y, Zhang Y, Lei Z, Liu T, Cai T, Wang A, Du W, Zeng Y, Zhu J, Liu Z, Huang JA. Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. J Hematol Oncol 2020;13:169. [PMID: 33287873 DOI: 10.1186/s13045-020-01009-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
75 Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C, Mantovani A, Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol 2010;185:642-52. [PMID: 20530259 DOI: 10.4049/jimmunol.1000413] [Cited by in Crossref: 251] [Cited by in F6Publishing: 240] [Article Influence: 20.9] [Reference Citation Analysis]
76 Khongsti K, Das KB, Das B. MAPK pathway and SIRT1 are involved in the down-regulation of secreted osteopontin expression by genistein in metastatic cancer cells. Life Sci 2021;265:118787. [PMID: 33249095 DOI: 10.1016/j.lfs.2020.118787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
77 Tajima K, Ohashi R, Sekido Y, Hida T, Nara T, Hashimoto M, Iwakami S, Minakata K, Yae T, Takahashi F, Saya H, Takahashi K. Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene 2010;29:1941-51. [DOI: 10.1038/onc.2009.478] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
78 Exley C, Charles LM, Barr L, Martin C, Polwart A, Darbre PD. Aluminium in human breast tissue. Journal of Inorganic Biochemistry 2007;101:1344-6. [DOI: 10.1016/j.jinorgbio.2007.06.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
79 Tang M, Jiang Y, Jia H, Patpur BK, Yang B, Li J, Yang C. Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease. Artif Cells Nanomed Biotechnol 2020;48:159-68. [PMID: 31852298 DOI: 10.1080/21691401.2019.1699822] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
80 Brockton NT, Gill SJ, Laborge SL, Paterson AH, Cook LS, Vogel HJ, Shemanko CS, Hanley DA, Magliocco AM, Friedenreich CM. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer. BMC Cancer 2015;15:512. [PMID: 26156521 DOI: 10.1186/s12885-015-1528-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
81 Kaleta B. The role of osteopontin in kidney diseases. Inflamm Res 2019;68:93-102. [PMID: 30456594 DOI: 10.1007/s00011-018-1200-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
82 Song G, Cai QF, Mao YB, Ming YL, Bao SD, Ouyang GL. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway. Cancer Sci 2008;99:1901-7. [PMID: 19016748 DOI: 10.1111/j.1349-7006.2008.00911.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 29] [Article Influence: 0.5] [Reference Citation Analysis]
83 Ke H, Chang L, Yang S, Lin H, Li C, Wu D, Wu W. Osteopontin overexpression predicts poor prognosis of upper urinary tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations 2011;29:703-9. [DOI: 10.1016/j.urolonc.2009.10.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
84 Ito K, Kon S, Nakayama Y, Kurotaki D, Saito Y, Kanayama M, Kimura C, Diao H, Morimoto J, Matsui Y, Uede T. The differential amino acid requirement within osteopontin in alpha4 and alpha9 integrin-mediated cell binding and migration. Matrix Biol 2009;28:11-9. [PMID: 19000758 DOI: 10.1016/j.matbio.2008.10.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
85 Holzinger J, Kotisch H, Richter KW, Konrat R. Binding Mode Characterization of Osteopontin on Hydroxyapatite by Solution NMR Spectroscopy. Chembiochem 2021;22:2300-5. [PMID: 33914399 DOI: 10.1002/cbic.202100139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Mishra M, Muthuramu I, Aboumsallem JP, Kempen H, De Geest B. Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice. Int J Mol Sci 2018;19:E3399. [PMID: 30380754 DOI: 10.3390/ijms19113399] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
87 Kim HL, Lee MY, Shin YJ, Song DW, Park J, Chang BS, Lee JH. Increased Expression of Osteopontin in the Degenerating Striatum of Rats Treated with Mitochondrial Toxin 3-Nitropropionic Acid: A Light and Electron Microscopy Study. Acta Histochem Cytochem 2015;48:135-43. [PMID: 26633905 DOI: 10.1267/ahc.15010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci. 2008;103:4-13. [PMID: 17890765 DOI: 10.1093/toxsci/kfm246] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 7.9] [Reference Citation Analysis]
89 Tang L, Chen Y, Peng X, Zhou Y, Jiang H, Wang G, Zhuang W. Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis. Front Genet 2020;11:521004. [PMID: 33362844 DOI: 10.3389/fgene.2020.521004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Cheng X, Zhu JL, Li Y, Luo WW, Xiang HR, Zhang QZ, Peng WX. Serum biomarkers of isoniazid-induced liver injury: Aminotransferases are insufficient, and OPN, L-FABP and HMGB1 can be promising novel biomarkers. J Appl Toxicol 2021. [PMID: 34494278 DOI: 10.1002/jat.4236] [Reference Citation Analysis]
91 Yan Y, Lang BT, Vemuganti R, Dempsey RJ. Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage. Journal of Neurochemistry 2009;109:1624-35. [DOI: 10.1111/j.1471-4159.2009.06059.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
92 Ding W, Yousefi K, Goncalves S, Goldstein BJ, Sabater AL, Kloosterboer A, Ritter P, Lambert G, Mendez AJ, Shehadeh LA. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits. JCI Insight 2018;3:94818. [PMID: 29563333 DOI: 10.1172/jci.insight.94818] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
93 Panebianco C, Saracino C, Pazienza V. Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression. Tumour Biol 2014;35:7307-15. [PMID: 24833096 DOI: 10.1007/s13277-014-2075-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
94 Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10573-10583 [PMID: 26457017 DOI: 10.3748/wjg.v21.i37.10573] [Cited by in CrossRef: 188] [Cited by in F6Publishing: 182] [Article Influence: 26.9] [Reference Citation Analysis]
95 Koukouli E, Wang D, Dondelinger F, Park J. A regularized functional regression model enabling transcriptome-wide dosage-dependent association study of cancer drug response. PLoS Comput Biol 2021;17:e1008066. [PMID: 33493149 DOI: 10.1371/journal.pcbi.1008066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Konstantakou EG, Velentzas AD, Anagnostopoulos AK, Litou ZI, Konstandi OA, Giannopoulou AF, Anastasiadou E, Voutsinas GE, Tsangaris GT, Stravopodis DJ. Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets. PLoS One 2017;12:e0171512. [PMID: 28158294 DOI: 10.1371/journal.pone.0171512] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
97 Yang GH, Fan J, Xu Y, Qiu SJ, Yang XR, Shi GM, Wu B, Dai Z, Liu YK, Tang ZY. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Oncologist. 2008;13:1155-1165. [PMID: 18997126 DOI: 10.1634/theoncologist.2008-0081] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
98 Malaval L, Wade-Guéye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux JP, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust MH, Amédée J, Vico L, Rossant J, Aubin JE. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 2008;205:1145-53. [PMID: 18458111 DOI: 10.1084/jem.20071294] [Cited by in Crossref: 159] [Cited by in F6Publishing: 133] [Article Influence: 11.4] [Reference Citation Analysis]
99 Ahmed M, Kundu GC. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Mol Cancer 2010;9:101. [PMID: 20459645 DOI: 10.1186/1476-4598-9-101] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
100 Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, Säemann MD, Geyeregger R, Schlederer M, Kenner L. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes. 2010;59:935-946. [PMID: 20107108 DOI: 10.2337/db09-0404] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 10.3] [Reference Citation Analysis]
101 Ahmed M, Behera R, Chakraborty G, Jain S, Kumar V, Sharma P, Bulbule A, Kale S, Kumar S, Mishra R, Raja R, Saraswati S, Kaur R, Soundararajan G, Kumar D, Thorat D, Sanyal M, Ramdasi A, Ghosh P, Kundu GC. Osteopontin: a potentially important therapeutic target in cancer. Expert Opin Ther Targets 2011;15:1113-26. [PMID: 21718227 DOI: 10.1517/14728222.2011.594438] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
102 Liu L, Jiang R, Lönnerdal B. Assessment of bioactivities of the human milk lactoferrin–osteopontin complex in vitro. The Journal of Nutritional Biochemistry 2019;69:10-8. [DOI: 10.1016/j.jnutbio.2019.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
103 Čebatariūnienė A, Jarmalavičiūtė A, Tunaitis V, Pūrienė A, Venalis A, Pivoriūnas A. Microcarrier culture enhances osteogenic potential of human periodontal ligament stromal cells. Journal of Cranio-Maxillofacial Surgery 2017;45:845-54. [DOI: 10.1016/j.jcms.2017.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
104 Coniglio SJ, Segall JE. Review: Molecular mechanism of microglia stimulated glioblastoma invasion. Matrix Biology 2013;32:372-80. [DOI: 10.1016/j.matbio.2013.07.008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
105 Malaponte G, Hafsi S, Polesel J, Castellano G, Spessotto P, Guarneri C, Canevari S, Signorelli SS, McCubrey JA, Libra M. Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression. Biochim Biophys Acta 2016;1863:483-9. [PMID: 26381542 DOI: 10.1016/j.bbamcr.2015.09.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
106 Saeg F, Anbalagan M. Breast cancer stem cells and the challenges of eradication: a review of novel therapies. Stem Cell Investig 2018;5:39. [PMID: 30498750 DOI: 10.21037/sci.2018.10.05] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
107 Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med. 2010;14:2037-2044. [PMID: 20597997 DOI: 10.1111/j.1582-4934.2010.01115.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 119] [Article Influence: 9.7] [Reference Citation Analysis]
108 Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M. Osteopontin as a molecular prognostic marker for melanoma. Cancer. 2008;112:144-150. [PMID: 18023025 DOI: 10.1002/cncr.23147] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 5.3] [Reference Citation Analysis]
109 Ermakov S, Leonov A, Trofimov S, Malkin I, Livshits G. Quantitative genetic study of the circulating osteopontin in community-selected families. Osteoporos Int 2011;22:2261-71. [DOI: 10.1007/s00198-010-1451-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
110 Chen T, Sun L, He C, Gong Y, Xu Q, Yuan Y. Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors. PLoS One 2014;9:e114005. [PMID: 25479069 DOI: 10.1371/journal.pone.0114005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
111 Puxeddu I, Berkman N, Ribatti D, Bader R, Haitchi HM, Davies DE, Howarth PH, Levi-Schaffer F. Osteopontin is expressed and functional in human eosinophils. Allergy 2010;65:168-74. [PMID: 19804447 DOI: 10.1111/j.1398-9995.2009.02148.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
112 Hsu LH, Liu KJ, Tsai MF, Wu CR, Feng AC, Chu NM, Kao SH. Estrogen adversely affects the prognosis of patients with lung adenocarcinoma. Cancer Sci 2015;106:51-9. [PMID: 25338663 DOI: 10.1111/cas.12558] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
113 Sun L, Tu H, Chen T, Yuan Q, Liu J, Dong N, Yuan Y. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer. Sci Rep 2017;7:11621. [PMID: 28912586 DOI: 10.1038/s41598-017-12022-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
114 Su X, Xu BH, Zhou DL, Ye ZL, He HC, Yang XH, Zhang X, Liu Q, Ma JJ, Shao Q, Yang AK, He CY. Polymorphisms in matricellular SPP1 and SPARC contribute to susceptibility to papillary thyroid cancer. Genomics 2020;112:4959-67. [PMID: 32919020 DOI: 10.1016/j.ygeno.2020.09.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Yu DD, Guo SW, Jing YY, Dong YL, Wei LX. A review on hepatocyte nuclear factor-1beta and tumor. Cell Biosci 2015;5:58. [PMID: 26464794 DOI: 10.1186/s13578-015-0049-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
116 Ito K, Nakajima A, Fukushima Y, Suzuki K, Sakamoto K, Hamazaki Y, Ogasawara K, Minato N, Hattori M. The potential role of Osteopontin in the maintenance of commensal bacteria homeostasis in the intestine. PLoS One 2017;12:e0173629. [PMID: 28296922 DOI: 10.1371/journal.pone.0173629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
117 Friedmann-Morvinski D, Bhargava V, Gupta S, Verma IM, Subramaniam S. Identification of therapeutic targets for glioblastoma by network analysis. Oncogene 2016;35:608-20. [PMID: 25961929 DOI: 10.1038/onc.2015.119] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
118 Yang YF, Chang YC, Jan YH, Yang CJ, Huang MS, Hsiao M. Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway. Oncogenesis 2020;9:78. [PMID: 32862200 DOI: 10.1038/s41389-020-00262-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
119 Yang MC, Wang HC, Hou YC, Tung HL, Chiu TJ, Shan YS. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol Cancer 2015;14:179. [PMID: 26458814 DOI: 10.1186/s12943-015-0449-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 13.0] [Reference Citation Analysis]
120 Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, Gorain M, Kale S, Kumar D, Kumar S, Totakura KV, Roy G, Sharma P, Shetti D, Soundararajan G, Thorat D, Tomar D, Nalukurthi R, Raja R, Mishra R, Yadav AS, Kundu GC. Osteopontin as a therapeutic target for cancer. Expert Opinion on Therapeutic Targets 2014;18:883-95. [DOI: 10.1517/14728222.2014.925447] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
121 Lee MN, Song JH, Oh SH, Tham NT, Kim JW, Yang JW, Kim ES, Koh JT. The primary cilium directs osteopontin-induced migration of mesenchymal stem cells by regulating CD44 signaling and Cdc42 activation. Stem Cell Res 2020;45:101799. [PMID: 32339903 DOI: 10.1016/j.scr.2020.101799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Neves RL, Chiarantin GMD, Nascimento FD, Pesquero JB, Nader HB, Tersariol ILS, McKee MD, Carmona AK, Barros NMT. Expression and inactivation of osteopontin-degrading PHEX enzyme in squamous cell carcinoma. Int J Biochem Cell Biol 2016;77:155-64. [PMID: 27270332 DOI: 10.1016/j.biocel.2016.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
123 Pazolli E, Alspach E, Milczarek A, Prior J, Piwnica-Worms D, Stewart SA. Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res 2012;72:2251-61. [PMID: 22422937 DOI: 10.1158/0008-5472.CAN-11-3386] [Cited by in Crossref: 100] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
124 Song G, Ming Y, Mao Y, Bao S, Ouyang G. Osteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via alpha v beta 3 integrins in human gastric cancer cells. Exp Biol Med (Maywood). 2008;233:1537-1545. [PMID: 18849546 DOI: 10.3181/0805-rm-164] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
125 Manini I, Caponnetto F, Dalla E, Ius T, Della Pepa GM, Pegolo E, Bartolini A, La Rocca G, Menna G, Di Loreto C, Olivi A, Skrap M, Sabatino G, Cesselli D. Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways. Cancers (Basel) 2020;12:E2960. [PMID: 33066172 DOI: 10.3390/cancers12102960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Yuan YS, Xie MQ, Qian ZH, Zhang XY, Yan DJ, Yu Y. Osteopontin: an important molecule in liver diseases. Shijie Huaren Xiaohua Zazhi 2011; 19(8): 814-819 [DOI: 10.11569/wcjd.v19.i8.814] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Castilla C, Flores ML, Conde JM, Medina R, Torrubia FJ, Japón MA, Sáez C. Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells. Clin Exp Metastasis 2012;29:349-58. [PMID: 22274591 DOI: 10.1007/s10585-012-9455-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
128 Wang YP, Liu BY. High expression of osteopontin and CD44v6 in odontogenic keratocysts. J Formos Med Assoc 2009;108:286-92. [PMID: 19369175 DOI: 10.1016/S0929-6646(09)60068-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
129 Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, Grami Z, Kong LY, Ling X, Caruso H, Zhou S, Wang YA, Fuller GN, Huse J, Gilboa E, Kang N, Huang X, Verhaak R, Li S, Heimberger AB. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Invest 2019;129:137-49. [PMID: 30307407 DOI: 10.1172/JCI121266] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 20.0] [Reference Citation Analysis]
130 He C, Sheng L, Pan D, Jiang S, Ding L, Ma X, Liu Y, Jia D. Single-Cell Transcriptomic Analysis Revealed a Critical Role of SPP1/CD44-Mediated Crosstalk Between Macrophages and Cancer Cells in Glioma. Front Cell Dev Biol 2021;9:779319. [PMID: 34805184 DOI: 10.3389/fcell.2021.779319] [Reference Citation Analysis]
131 Abdalrhim AD, Marroush TS, Austin EE, Gersh BJ, Solak N, Rizvi SA, Bailey KR, Kullo IJ. Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial. PLoS One 2016;11:e0156965. [PMID: 27284698 DOI: 10.1371/journal.pone.0156965] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
132 Luna-Luna M, Medina-Urrutia A, Vargas-Alarcón G, Coss-Rovirosa F, Vargas-Barrón J, Pérez-Méndez Ó. Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis. Arch Med Res 2015;46:392-407. [PMID: 26009250 DOI: 10.1016/j.arcmed.2015.05.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
133 Schulz G, Renkl AC, Seier A, Liaw L, Weiss JM. Regulated osteopontin expression by dendritic cells decisively affects their migratory capacity. J Invest Dermatol 2008;128:2541-4. [PMID: 18449212 DOI: 10.1038/jid.2008.112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
134 Pleil JD, Wallace MAG, Mccord J, Madden MC, Sobus J, Ferguson G. How do cancer-sniffing dogs sort biological samples? Exploring case-control samples with non-targeted LC-Orbitrap, GC-MS, and immunochemistry methods. J Breath Res 2020;14:016006. [DOI: 10.1088/1752-7163/ab433a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
135 Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS. Hepatocellualar carcinoma serum markers. Semin Oncol. 2012;39:410-433. [PMID: 22846859 DOI: 10.1053/j.seminoncol.2012.05.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 10.3] [Reference Citation Analysis]
136 Pazolli E, Luo X, Brehm S, Carbery K, Chung JJ, Prior JL, Doherty J, Demehri S, Salavaggione L, Piwnica-Worms D, Stewart SA. Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res 2009;69:1230-9. [PMID: 19155301 DOI: 10.1158/0008-5472.CAN-08-2970] [Cited by in Crossref: 89] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
137 Carrer A, Zacchigna S, Balani A, Pistan V, Adami A, Porcelli F, Scaramucci M, Roseano M, Turoldo A, Prati MC, Dell'Omodarme M, de Manzini N, Giacca M. Expression profiling of angiogenic genes for the characterisation of colorectal carcinoma. Eur J Cancer 2008;44:1761-9. [PMID: 18656346 DOI: 10.1016/j.ejca.2008.05.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
138 Minai-tehrani A, Jiang H, Kim Y, Chung Y, Yu K, Kim J, Shin J, Hong S, Lee J, Kim H, Chang S, Park S, Kang BN, Cho C, Cho M. Suppression of tumor growth in xenograft model mice by small interfering RNA targeting osteopontin delivery using biocompatible poly(amino ester). International Journal of Pharmaceutics 2012;431:197-203. [DOI: 10.1016/j.ijpharm.2012.04.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
139 Cao L, Fan X, Jing W, Liang Y, Chen R, Liu Y, Zhu M, Jia R, Wang H, Zhang X, Zhang Y, Zhou X, Zhao J, Guo Y. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway. Oncotarget 2015;6:6627-40. [PMID: 25749383 DOI: 10.18632/oncotarget.3113] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
140 Adams CR, Htwe HH, Marsh T, Wang AL, Montoya ML, Subbaraj L, Tward AD, Bardeesy N, Perera RM. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. Elife 2019;8:e45313. [PMID: 31134896 DOI: 10.7554/eLife.45313] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 9.7] [Reference Citation Analysis]
141 Fang X, Yin Z, Li X, Xia L, Quan X, Zhao Y, Zhou B. Multiple functional SNPs in differentially expressed genes modify risk and survival of non-small cell lung cancer in Chinese female non-smokers. Oncotarget 2017;8:18924-34. [PMID: 28148898 DOI: 10.18632/oncotarget.14836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
142 Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007;92:3719-27. [PMID: 17595250 DOI: 10.1210/jc.2007-0349] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 9.5] [Reference Citation Analysis]
143 Kumar D, Kumar S, Gorain M, Tomar D, Patil HS, Radharani NNV, Kumar TVS, Patil TV, Thulasiram HV, Kundu GC. Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis. J Invest Dermatol 2016;136:2462-74. [PMID: 27476721 DOI: 10.1016/j.jid.2016.07.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
144 Hao C, Wang Z, Gu Y, Jiang WG, Cheng S. Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis. Biomed Res Int 2016;2016:7310694. [PMID: 27462610 DOI: 10.1155/2016/7310694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
145 Zhao C, Fancy SP, ffrench-Constant C, Franklin RJ. Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiol Dis 2008;31:209-17. [PMID: 18539470 DOI: 10.1016/j.nbd.2008.04.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
146 Thomas LE, Winston J, Rad E, Mort M, Dodd KM, Tee AR, McDyer F, Moore S, Cooper DN, Upadhyaya M. Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours. Hum Genomics 2015;9:3. [PMID: 25884485 DOI: 10.1186/s40246-015-0025-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
147 Pearce CJ, Conrad ME, Nolan PE, Fishbein DB, Dawson JE. Ehrlichiosis: a cause of bone marrow hypoplasia in humans. Am J Hematol. 1988;28:53-55. [PMID: 3369436 DOI: 10.1155/2012/708036] [Cited by in Crossref: 252] [Cited by in F6Publishing: 263] [Article Influence: 7.4] [Reference Citation Analysis]
148 Moldogazieva NT, Mokhosoev IM, Zavadskiy SP, Terentiev AA. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines 2021;9:159. [PMID: 33562077 DOI: 10.3390/biomedicines9020159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
149 Schneider D, Liaw L, Daniel C, Athanasopoulos AN, Herrmann M, Preissner KT, Nawroth PP, Chavakis T. Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus. Biochem Biophys Res Commun 2007;357:282-8. [PMID: 17418809 DOI: 10.1016/j.bbrc.2007.03.143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
150 Fickert P, Stöger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol. 2007;171:525-536. [PMID: 17600122 DOI: 10.2353/ajpath.2007.061133] [Cited by in Crossref: 214] [Cited by in F6Publishing: 202] [Article Influence: 14.3] [Reference Citation Analysis]
151 Godavarthy PS, Kumar R, Herkt SC, Pereira RS, Hayduk N, Weissenberger ES, Aggoune D, Manavski Y, Lucas T, Pan KT, Voutsinas JM, Wu Q, Müller MC, Saussele S, Oellerich T, Oehler VG, Lausen J, Krause DS. The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis. Haematologica 2020;105:136-47. [PMID: 31018977 DOI: 10.3324/haematol.2018.212365] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
152 Melve GK, Ersvaer E, Akkök ÇA, Ahmed AB, Kristoffersen EK, Hervig T, Bruserud Ø. Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor. Int J Mol Sci 2016;17:E1158. [PMID: 27447610 DOI: 10.3390/ijms17071158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology. 2008;149:1350-1357. [PMID: 18048491 DOI: 10.1210/en.2007-1312] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 6.5] [Reference Citation Analysis]
154 Yao XX, Lu JB, Ye ZD, Zheng L, Wang Q, Lin ZQ, Liu H, Wan H, Fu FY, Huang XY, Xiu JC, Liu ZJ, Hu YW. Hairy/enhancer of Split Homologue-1 Suppresses Vascular Endothelial Growth Factor-induced Angiogenesis via Downregulation of Osteopontin Expression. Sci Rep 2017;7:898. [PMID: 28420872 DOI: 10.1038/s41598-017-01018-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Ock CY, Nam AR, Lee J, Bang JH, Lee KH, Han SW, Kim TY, Im SA, Kim TY, Bang YJ, Oh DY. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer. Gastric Cancer. 2017;20:254-262. [PMID: 27147244 DOI: 10.1007/s10120-016-0613-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
156 Chen Z, Brito LF, Luo H, Shi R, Chang Y, Liu L, Guo G, Wang Y. Genetic and Genomic Analyses of Service Sire Effect on Female Reproductive Traits in Holstein Cattle. Front Genet 2021;12:713575. [PMID: 34539741 DOI: 10.3389/fgene.2021.713575] [Reference Citation Analysis]
157 Jia R, Liang Y, Chen R, Liu G, Wang H, Tang M, Zhou X, Wang H, Yang Y, Wei H, Li B, Song Y, Zhao J. Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity. Cell Death Dis 2016;7:e2564. [PMID: 28032860 DOI: 10.1038/cddis.2016.422] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
158 Al-Swiahb JN, Chen CH, Chuang HC, Fang FM, Tasi HT, Chien CY. Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity. Future Oncol 2010;6:837-50. [PMID: 20465394 DOI: 10.2217/fon.10.35] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
159 Walker ME, Hatfield JK, Brown MA. New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim Biophys Acta 2012;1822:57-65. [PMID: 21354470 DOI: 10.1016/j.bbadis.2011.02.009] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
160 Lee YJ, Jang BK. Can combination of osteopontin and peritumor-infiltrating macrophages be a prognostic marker of early-stage hepatocellular carcinoma? Hepatobiliary Surg Nutr 2014;3:57-9. [PMID: 24812596 DOI: 10.3978/j.issn.2304-3881.2014.02.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Guo S, Ravi A, Mayfield S, L Nikolov Z. Exploring the separation power of mixed-modal resins for purification of recombinant osteopontin from clarified Escherichia coli lysates. Biotechnol Prog 2019;35:e2722. [PMID: 30298998 DOI: 10.1002/btpr.2722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 2009;66:2219-2230. [PMID: 19308325 DOI: 10.1007/s00018-009-0013-7] [Cited by in Crossref: 223] [Cited by in F6Publishing: 214] [Article Influence: 17.2] [Reference Citation Analysis]
163 Wang JB, Zhang Z, Li JN, Yang T, Du S, Cao RJ, Cui SS. SPP1 promotes Schwann cell proliferation and survival through PKCα by binding with CD44 and αvβ3 after peripheral nerve injury. Cell Biosci 2020;10:98. [PMID: 32843960 DOI: 10.1186/s13578-020-00458-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Matsuura M, Suzuki T, Saito T. Osteopontin is a new target molecule for ovarian clear cell carcinoma therapy. Cancer Sci 2010;101:1828-33. [PMID: 20545695 DOI: 10.1111/j.1349-7006.2010.01615.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
165 Remus EW, Lyle AN, Weiss D, Landàzuri N, Weber M, Searles C, Taylor WR. miR181a protects against angiotensin II-induced osteopontin expression in vascular smooth muscle cells. Atherosclerosis 2013;228:168-74. [PMID: 23466073 DOI: 10.1016/j.atherosclerosis.2013.01.037] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
166 Liersch R, Gerss J, Schliemann C, Bayer M, Schwöppe C, Biermann C, Appelmann I, Kessler T, Löwenberg B, Büchner T, Hiddemann W, Müller-tidow C, Berdel WE, Mesters R. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients. Blood 2012;119:5215-20. [DOI: 10.1182/blood-2011-11-389692] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
167 Castello LM, Raineri D, Salmi L, Clemente N, Vaschetto R, Quaglia M, Garzaro M, Gentilli S, Navalesi P, Cantaluppi V, Dianzani U, Aspesi A, Chiocchetti A. Osteopontin at the Crossroads of Inflammation and Tumor Progression. Mediators Inflamm 2017;2017:4049098. [PMID: 28769537 DOI: 10.1155/2017/4049098] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 14.2] [Reference Citation Analysis]
168 Tang H, Wang J, Bai F, Zhai H, Gao J, Hong L, Xie H, Zhang F, Lan M, Yao W. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer. Cancer Invest. 2008;26:60-67. [PMID: 18181047 DOI: 10.1080/07357900701519279] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
169 Li J, Ramani K, Sun Z, Zee C, Grant EG, Yang H, Xia M, Oh P, Ko K, Mato JM, Lu SC. Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. Am J Pathol 2010;176:2456-66. [PMID: 20363925 DOI: 10.2353/ajpath.2010.090810] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
170 Zhao F, Chen X, Meng T, Hao B, Zhang Z, Zhang G. Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer. BMC Cancer 2012;12:477. [PMID: 23072570 DOI: 10.1186/1471-2407-12-477] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
171 Hsu KH, Tsai HW, Lin PW, Hsu YS, Shan YS, Lu PJ. Osteopontin expression is an independent adverse prognostic factor in resectable gastrointestinal stromal tumor and its interaction with CD44 promotes tumor proliferation. Ann Surg Oncol. 2010;17:3043-3052. [PMID: 20549562 DOI: 10.1245/s10434-010-1143-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
172 Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X, Shi J, Li Z, Zhang J, Chen W. Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway. Theranostics 2018;8:921-40. [PMID: 29463991 DOI: 10.7150/thno.22182] [Cited by in Crossref: 43] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
173 Han X, Wang W, He J, Jiang L, Li X. Osteopontin as a biomarker for osteosarcoma therapy and prognosis. Oncol Lett 2019;17:2592-8. [PMID: 30854034 DOI: 10.3892/ol.2019.9905] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
174 Subramani VN, Narasimhan M, Thiyagarajan M, Munuswamy BD, Jayamani L. Expression of Osteopontin in Oral Squamous Cell Carcinoma and its Surgical Margins-An Immunohistochemical Study. J Clin Diagn Res 2015;9:ZC66-9. [PMID: 26675878 DOI: 10.7860/JCDR/2015/12777.6836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
175 Li L, Li X, Li L, Wang J, Jin W. Ultra-sensitive DNA assay based on single-molecule detection coupled with fluorescent quantum dot-labeling and its application to determination of messenger RNA. Analytica Chimica Acta 2011;685:52-7. [DOI: 10.1016/j.aca.2010.11.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
176 Suzuki H, Ayer R, Sugawara T, Chen W, Sozen T, Hasegawa Y, Kanamaru K, Zhang JH. Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats. Crit Care Med 2010;38:612-8. [PMID: 19851092 DOI: 10.1097/CCM.0b013e3181c027ae] [Cited by in Crossref: 81] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
177 Miyatani K, Saito H, Kono Y, Murakami Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Combined analysis of the pre- and postoperative neutrophil–lymphocyte ratio predicts the outcomes of patients with gastric cancer. Surg Today 2018;48:300-7. [DOI: 10.1007/s00595-017-1587-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
178 Robertson BW, Bonsal L, Chellaiah MA. Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells. Mol Cancer 2010;9:260. [PMID: 20868520 DOI: 10.1186/1476-4598-9-260] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
179 Ni Q, Ji H, Zhao Z, Fan X, Xu C. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism. European Journal of Pharmacology 2009;614:1-6. [DOI: 10.1016/j.ejphar.2009.04.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
180 Tassinari R, Narciso L, Tait S, Busani L, Martinelli A, Di Virgilio A, Carli F, Deodati A, La Rocca C, Maranghi F; LIFE PERSUADED Project Group. Juvenile Toxicity Rodent Model to Study Toxicological Effects of Bisphenol A (BPA) at Dose Levels Derived From Italian Children Biomonitoring Study. Toxicol Sci 2020;173:387-401. [PMID: 31697385 DOI: 10.1093/toxsci/kfz226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
181 Baliga SS, Merrill GF, Shinohara ML, Denhardt DT. Osteopontin expression during early cerebral ischemia-reperfusion in rats: enhanced expression in the right cortex is suppressed by acetaminophen. PLoS One 2011;6:e14568. [PMID: 21283687 DOI: 10.1371/journal.pone.0014568] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
182 Sivakumar S, Niranjali Devaraj S. Tertiary structure prediction and identification of druggable pocket in the cancer biomarker - Osteopontin-c. J Diabetes Metab Disord 2014;13:13. [PMID: 24401206 DOI: 10.1186/2251-6581-13-13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
183 Jiang R, Liu L, Du X, Lönnerdal B. Evaluation of Bioactivities of the Bovine Milk Lactoferrin-Osteopontin Complex in Infant Formulas. J Agric Food Chem 2020;68:6104-11. [PMID: 32362125 DOI: 10.1021/acs.jafc.9b07988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Kamioka Y, Takakura K, Sumiyama K, Matsuda M. Intravital Förster resonance energy transfer imaging reveals osteopontin-mediated polymorphonuclear leukocyte activation by tumor cell emboli. Cancer Sci 2017;108:226-35. [PMID: 27960041 DOI: 10.1111/cas.13132] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
185 Zhao W, Wang L, Zhang L, Yuan C, Kuo PC, Gao C. Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists. J Biol Chem 2010;285:20452-61. [PMID: 20427276 DOI: 10.1074/jbc.M110.110312] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
186 Güttler A, Giebler M, Cuno P, Wichmann H, Keßler J, Ostheimer C, Söling A, Strauss C, Illert J, Kappler M, Vordermark D, Bache M. Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy. Radiother Oncol 2013;108:535-40. [PMID: 23891093 DOI: 10.1016/j.radonc.2013.06.036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
187 Cervello M, Augello G, Cusimano A, Emma MR, Balasus D, Azzolina A, Mccubrey JA, Montalto G. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma. Advances in Biological Regulation 2017;65:59-76. [DOI: 10.1016/j.jbior.2017.06.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
188 Kaleta B, Krata N, Zagożdżon R, Mucha K. Osteopontin Gene Polymorphism and Urinary OPN Excretion in Patients with Immunoglobulin A Nephropathy. Cells 2019;8:E524. [PMID: 31159229 DOI: 10.3390/cells8060524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology. 2008;48:1834-1842. [PMID: 18972404 DOI: 10.1002/hep.22531] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 8.7] [Reference Citation Analysis]
190 Han B, Huang J, Han Y, Hao J, Wu X, Song H, Chen X, Shen Q, Dong X, Pang H, Cai L. The microRNA miR-181c enhances chemosensitivity and reduces chemoresistance in breast cancer cells via down-regulating osteopontin. International Journal of Biological Macromolecules 2019;125:544-56. [DOI: 10.1016/j.ijbiomac.2018.12.075] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
191 Abdulrahman N, Jaballah M, Poomakkoth N, Riaz S, Abdelaziz S, Issa A, Mraiche F. Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin. Mol Cell Biochem 2016;418:21-9. [PMID: 27236820 DOI: 10.1007/s11010-016-2727-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
192 Chen S, Chen L, Jahangiri A, Chen B, Wu Y, Chuang HH, Qin C, MacDougall M. Expression and processing of small integrin-binding ligand N-linked glycoproteins in mouse odontoblastic cells. Arch Oral Biol 2008;53:879-89. [PMID: 18582847 DOI: 10.1016/j.archoralbio.2008.05.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
193 Eldawud R, Reitzig M, Opitz J, Rojansakul Y, Jiang W, Nangia S, Dinu CZ. Combinatorial approaches to evaluate nanodiamond uptake and induced cellular fate. Nanotechnology 2016;27:085107. [PMID: 26820775 DOI: 10.1088/0957-4484/27/8/085107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
194 Liersch R, Shin JW, Bayer M, Schwöppe C, Schliemann C, Berdel WE, Mesters R, Detmar M. Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor. Int J Oncol 2012;41:1455-63. [PMID: 22797548 DOI: 10.3892/ijo.2012.1548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
195 Uhlmann ME, Georgieva M, Sill M, Linnemann U, Berger MR. Prognostic value of tumor progression-related gene expression in colorectal cancer patients. J Cancer Res Clin Oncol 2012;138:1631-40. [DOI: 10.1007/s00432-012-1238-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
196 Karakan S, Sezer S, Özdemir Acar F, Haberal M. Circulating Levels of Osteopontin Are Related With Calcification Parameters in Patients With Renal Transplantations. Transplantation Proceedings 2011;43:562-4. [DOI: 10.1016/j.transproceed.2011.01.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
197 Rodrigo JP, García-pedrero JM, Suárez C, Takes RP, Thompson LDR, Slootweg PJ, Woolgar JA, Westra WH, Brakenhoff RH, Rinaldo A, Devaney KO, Williams MD, Gnepp DR, Ferlito A. Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review. Eur Arch Otorhinolaryngol 2012;269:1073-83. [DOI: 10.1007/s00405-011-1831-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
198 Liu G, Fan X, Tang M, Chen R, Wang H, Jia R, Zhou X, Jing W, Wang H, Yang Y. Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells. Cancer Lett. 2016;383:171-182. [PMID: 27702661 DOI: 10.1016/j.canlet.2016.09.033] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
199 Wei T, Bi G, Bian Y, Ruan S, Yuan G, Xie H, Zhao M, Shen R, Zhu Y, Wang Q, Yang Y, Zhu D. The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers. Front Mol Biosci 2020;7:565383. [PMID: 33324676 DOI: 10.3389/fmolb.2020.565383] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Platzer G, Żerko S, Saxena S, Koźmiński W, Konrat R. (1)H, (15)N, (13)C resonance assignment of human osteopontin. Biomol NMR Assign 2015;9:289-92. [PMID: 25616494 DOI: 10.1007/s12104-014-9594-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
201 Song G, Ouyang G, Mao Y, Ming Y, Bao S, Hu T. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation. J Cell Mol Med. 2009;13:1706-1718. [PMID: 19602039 DOI: 10.1111/j.1582-4934.2008.00540.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
202 Labrousse-arias D, Martínez-ruiz A, Calzada MJ. Hypoxia and Redox Signaling on Extracellular Matrix Remodeling: From Mechanisms to Pathological Implications. Antioxidants & Redox Signaling 2017;27:802-22. [DOI: 10.1089/ars.2017.7275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
203 Chakraborty G, Jain S, Patil TV, Kundu GC. Down-regulation of osteopontin attenuates breast tumour progression in vivo. J Cell Mol Med 2008;12:2305-18. [PMID: 18266970 DOI: 10.1111/j.1582-4934.2008.00263.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
204 Xu R, Tan H, Zhang J, Yuan Z, Xie Q, Zhang L. Fam20C in Human Diseases: Emerging Biological Functions and Therapeutic Implications. Front Mol Biosci 2021;8:790172. [PMID: 34988120 DOI: 10.3389/fmolb.2021.790172] [Reference Citation Analysis]
205 Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J. Molecular aspects of tumour hypoxia. Mol Oncol. 2008;2:41-53. [PMID: 19383328 DOI: 10.1016/j.molonc.2008.03.006] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 7.6] [Reference Citation Analysis]
206 Liu YJ, Zhang DQ, Sui XM, Tian W. Overexpression of human osteopontin increases cell proliferation and migration in human embryo kidney-293 cells. Cell Mol Biol Lett 2009;14:670-8. [PMID: 19562270 DOI: 10.2478/s11658-009-0027-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
207 Kazanecki CC, Uzwiak DJ, Denhardt DT. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem. 2007;102:912-924. [PMID: 17910028 DOI: 10.1002/jcb.21558] [Cited by in Crossref: 188] [Cited by in F6Publishing: 185] [Article Influence: 13.4] [Reference Citation Analysis]
208 Akbalik ME, Sagsoz H, Erdogan S. Osteopontin expression in the intestine of chukar partridge (Alectoris chukar, Gray, 1830). Animal Biol 2015;65:287-98. [DOI: 10.1163/15707563-00002477] [Reference Citation Analysis]
209 Lin F, Li Y, Cao J, Fan S, Wen J, Zhu G, Du H, Liang Y. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells. Mol Biol Rep. 2011;38:5205-5210. [PMID: 21188534 DOI: 10.1007/s11033-010-0671-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
210 Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, Mi Z, Pereira TA, Zdanowicz M, Malladi P. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology. 2011;53:106-115. [PMID: 20967826 DOI: 10.1002/hep.23998] [Cited by in Crossref: 163] [Cited by in F6Publishing: 159] [Article Influence: 13.6] [Reference Citation Analysis]
211 Fishel I, Kaufman A, Ruppin E. Meta-analysis of gene expression data: a predictor-based approach. Bioinformatics 2007;23:1599-606. [PMID: 17463023 DOI: 10.1093/bioinformatics/btm149] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
212 Zhang H, Liu HB, Yuan DM, Wang ZF, Wang YF, Song Y. Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer. BMC Cancer 2014;14:280. [PMID: 24758329 DOI: 10.1186/1471-2407-14-280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
213 Filia A, Elliott F, Wind T, Field S, Davies J, Kukalizch K, Randerson-Moor J, Harland M, Bishop DT, Banks RE, Newton-Bishop JA. Plasma osteopontin concentrations in patients with cutaneous melanoma. Oncol Rep 2013;30:1575-80. [PMID: 23934016 DOI: 10.3892/or.2013.2666] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
214 Haybaeck J, Stumptner C, Thueringer A, Kolbe T, Magin TM, Hesse M, Fickert P, Tsybrovskyy O, Müller H, Trauner M, Zatloukal K, Denk H. Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Lab Invest 2012;92:857-67. [PMID: 22449798 DOI: 10.1038/labinvest.2012.49] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
215 Chandra S, Srinivasan S, Batra J. Hepatocyte nuclear factor 1 beta: A perspective in cancer. Cancer Med 2021;10:1791-804. [PMID: 33580750 DOI: 10.1002/cam4.3676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Meng X, Lu H, Jiang X, Huang B, Wu S, Yu G, Cao H. Understanding the molecular association between hyperkalemia and lung squamous cell carcinomas. BMC Med Genet 2020;21:176. [PMID: 33092550 DOI: 10.1186/s12881-020-01099-7] [Reference Citation Analysis]
217 Kumar S, Sharma P, Kumar D, Chakraborty G, Gorain M, Kundu GC. Functional characterization of stromal osteopontin in melanoma progression and metastasis. PLoS One 2013;8:e69116. [PMID: 23935934 DOI: 10.1371/journal.pone.0069116] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
218 Zheng BW, Huang W, Liu FS, Zhang TL, Wang XB, Li J, Lv GH, Yan YG, Zou MX. Clinicopathological and Prognostic Characteristics in Spinal Chondroblastomas: A Pooled Analysis of Individual Patient Data From a Single Institute and 27 Studies. Global Spine J 2021;:21925682211005732. [PMID: 33896211 DOI: 10.1177/21925682211005732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
219 Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology. 2008;135:956-968. [PMID: 18555021 DOI: 10.1053/j.gastro.2008.05.025] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 6.5] [Reference Citation Analysis]
220 Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, Oakley F, Moles A, Mann DA, Bobola N, Sharrocks AD. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology. 2012;56:1108-1116. [PMID: 22488688 DOI: 10.1002/hep.25758] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 6.4] [Reference Citation Analysis]
221 Dong Q, Zhu X, Dai C, Zhang X, Gao X, Wei J, Sheng Y, Zheng Y, Yu J, Xie L, Qin Y, Qiao P, Zhou C, Yu X, Jia H, Ren N, Zhou H, Ye Q, Qin L. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin. Oncotarget 2016;7:12997-3012. [PMID: 26824421 DOI: 10.18632/oncotarget.7016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
222 Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, Chen CJ, Chi NH, Chen GH, Lin JT. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut. 2007;56:782-789. [PMID: 17148500 DOI: 10.1136/gut.2006.109868] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
223 Shurin MR. Osteopontin controls immunosuppression in the tumor microenvironment. J Clin Invest 2018;128:5209-12. [PMID: 30395537 DOI: 10.1172/JCI124918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
224 Hahnel A, Wichmann H, Greither T, Kappler M, Würl P, Kotzsch M, Taubert H, Vordermark D, Bache M. Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients. BMC Cancer 2012;12:131. [PMID: 22471890 DOI: 10.1186/1471-2407-12-131] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
225 Pezzuto B, Badagliacca R, Poscia R, Ghio S, D’alto M, Vitulo P, Mulè M, Albera C, Volterrani M, Fedele F, Vizza CD. Circulating biomarkers in pulmonary arterial hypertension: Update and future direction. The Journal of Heart and Lung Transplantation 2015;34:282-305. [DOI: 10.1016/j.healun.2014.12.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
226 Liu Y, Chen L, Jiang D, Luan L, Huang J, Hou Y, Xu C. HER2 promotes epithelial-mesenchymal transition through regulating osteopontin in gastric cancer. Pathol Res Pract 2021;227:153643. [PMID: 34634565 DOI: 10.1016/j.prp.2021.153643] [Reference Citation Analysis]
227 Butti R, Ghosh P, Totakura KVS, Venkata RNN, Nimma R, Kundu GC. Role of Osteopontin in Tumor Microenvironment: A New Paradigm in Cancer Therapy. In: Gandhi V, Mehta K, Grover R, Pathak S, Aggarwal BB, editors. Multi-Targeted Approach to Treatment of Cancer. Cham: Springer International Publishing; 2015. pp. 113-25. [DOI: 10.1007/978-3-319-12253-3_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
228 Yamamoto T, Oishi T, Higo N, Murayama S, Sato A, Takashima I, Sugiyama Y, Nishimura Y, Murata Y, Yoshino-Saito K, Isa T, Kojima T. Differential expression of secreted phosphoprotein 1 in the motor cortex among primate species and during postnatal development and functional recovery. PLoS One 2013;8:e65701. [PMID: 23741508 DOI: 10.1371/journal.pone.0065701] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
229 Uhlmann ME, Georges RB, Boleij A, Eyol E, Kubarenko A, Adwan H, Berger MR. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver. Cancer Gene Ther 2011;18:795-805. [PMID: 21852811 DOI: 10.1038/cgt.2011.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
230 Lorenzen JM, Hafer C, Faulhaber-walter R, Kumpers P, Kielstein JT, Haller H, Fliser D. Osteopontin predicts survival in critically ill patients with acute kidney injury. Nephrology Dialysis Transplantation 2011;26:531-7. [DOI: 10.1093/ndt/gfq498] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
231 Silva AL, Faria M, Matos P. Inflammatory Microenvironment Modulation of Alternative Splicing in Cancer: A Way to Adapt. Adv Exp Med Biol 2020;1219:243-58. [PMID: 32130703 DOI: 10.1007/978-3-030-34025-4_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
232 Yadav AS, Radharani NNV, Gorain M, Bulbule A, Shetti D, Roy G, Baby T, Kundu GC. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer. Nanoscale 2020;12:10664-84. [DOI: 10.1039/c9nr10673a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 8.5] [Reference Citation Analysis]
233 Saleh S, Thompson DE, McConkey J, Murray P, Moorehead RA. Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells. BMC Cancer 2016;16:359. [PMID: 27282619 DOI: 10.1186/s12885-016-2396-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
234 Zehnder T, Boccaccini AR, Detsch R. Biofabrication of a co-culture system in an osteoid-like hydrogel matrix. Biofabrication 2017;9:025016. [PMID: 28266351 DOI: 10.1088/1758-5090/aa64ec] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
235 Linhares MM, Affonso RJ Jr, Viana Lde S, Silva SR, Denadai MV, de Toledo SR, Matos D. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival. PLoS One 2015;10:e0144333. [PMID: 26674523 DOI: 10.1371/journal.pone.0144333] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
236 Boyerinas B, Zafrir M, Yesilkanal AE, Price TT, Hyjek EM, Sipkins DA. Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. Blood. 2013;121:4821-4831. [PMID: 23589674 DOI: 10.1182/blood-2012-12-475483] [Cited by in Crossref: 128] [Cited by in F6Publishing: 122] [Article Influence: 14.2] [Reference Citation Analysis]
237 Naba A, Clauser KR, Whittaker CA, Carr SA, Tanabe KK, Hynes RO. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer 2014;14:518. [PMID: 25037231 DOI: 10.1186/1471-2407-14-518] [Cited by in Crossref: 119] [Cited by in F6Publishing: 119] [Article Influence: 14.9] [Reference Citation Analysis]
238 Butti R, Nimma R, Kundu G, Bulbule A, Kumar TVS, Gunasekaran VP, Tomar D, Kumar D, Mane A, Gill SS, Patil T, Weber GF, Kundu GC. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression. Oncogene 2021;40:2002-17. [PMID: 33603163 DOI: 10.1038/s41388-021-01663-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 He C, Fan X, Chen R, Liang B, Cao L, Guo Y, Zhao J. Osteopontin is involved in estrogen-mediated protection against diethylnitrosamine-induced liver injury in mice. Food Chem Toxicol 2012;50:2878-85. [PMID: 22609492 DOI: 10.1016/j.fct.2012.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
240 Oler G, Camacho CP, Hojaij FC, Michaluart P Jr, Riggins GJ, Cerutti JM. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis. Clin Cancer Res 2008;14:4735-42. [PMID: 18676742 DOI: 10.1158/1078-0432.CCR-07-4372] [Cited by in Crossref: 57] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
241 Margagliotti S, Clotman F, Pierreux CE, Beaudry JB, Jacquemin P, Rousseau GG, Lemaigre FP. The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev Biol 2007;311:579-89. [PMID: 17936262 DOI: 10.1016/j.ydbio.2007.09.013] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 5.3] [Reference Citation Analysis]
242 Kontomanolis EN, Kalagasidou S, Pouliliou S, Anthoulaki X, Georgiou N, Papamanolis V, Fasoulakis ZN. The Notch Pathway in Breast Cancer Progression. ScientificWorldJournal 2018;2018:2415489. [PMID: 30111989 DOI: 10.1155/2018/2415489] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
243 Platzer G, Schedlbauer A, Chemelli A, Ozdowy P, Coudevylle N, Auer R, Kontaxis G, Hartl M, Miles AJ, Wallace BA, Glatter O, Bister K, Konrat R. The metastasis-associated extracellular matrix protein osteopontin forms transient structure in ligand interaction sites. Biochemistry 2011;50:6113-24. [PMID: 21609000 DOI: 10.1021/bi200291e] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
244 Seipel D, Oliveira BC, Resende TL, Schuindt SH, Pimentel PM, Kanashiro MM, Arnholdt AC. Toxoplasma gondii infection positively modulates the macrophages migratory molecular complex by increasing matrix metalloproteinases, CD44 and alpha v beta 3 integrin. Vet Parasitol 2010;169:312-9. [PMID: 20080350 DOI: 10.1016/j.vetpar.2009.12.042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
245 Kato N, Motoyama T. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression. Histopathology 2008;52:682-8. [PMID: 18393978 DOI: 10.1111/j.1365-2559.2008.03006.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
246 Maj E, Maj B, Bobak K, Gos M, Chodyński M, Kutner A, Wietrzyk J. Differential Response of Lung Cancer Cells, with Various Driver Mutations, to Plant Polyphenol Resveratrol and Vitamin D Active Metabolite PRI-2191. Int J Mol Sci 2021;22:2354. [PMID: 33652978 DOI: 10.3390/ijms22052354] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Honda M, Kimura C, Uede T, Kon S. Neutralizing antibody against osteopontin attenuates non-alcoholic steatohepatitis in mice. J Cell Commun Signal 2020;14:223-32. [PMID: 32062834 DOI: 10.1007/s12079-020-00554-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
248 Huang J, Duran A, Reina-Campos M, Valencia T, Castilla EA, Müller TD, Tschöp MH, Moscat J, Diaz-Meco MT. Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor. Cancer Cell 2018;33:770-784.e6. [PMID: 29634950 DOI: 10.1016/j.ccell.2018.03.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
249 Lorenzen JM, Nickel N, Krämer R, Golpon H, Westerkamp V, Olsson KM, Haller H, Hoeper MM. Osteopontin in Patients With Idiopathic Pulmonary Hypertension. Chest 2011;139:1010-7. [DOI: 10.1378/chest.10-1146] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
250 Kobori T, Hamasaki S, Kitaura A, Yamazaki Y, Nishinaka T, Niwa A, Nakao S, Wake H, Mori S, Yoshino T, Nishibori M, Takahashi H. Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis. Front Immunol 2018;9:334. [PMID: 29559970 DOI: 10.3389/fimmu.2018.00334] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
251 Mi Z, Guo H, Russell MB, Liu Y, Sullenger BA, Kuo PC. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells. Mol Ther. 2009;17:153-161. [PMID: 18985031 DOI: 10.1038/mt.2008.235] [Cited by in Crossref: 98] [Cited by in F6Publishing: 95] [Article Influence: 7.0] [Reference Citation Analysis]
252 Xu C, Li H, Yin M, Yang T, An L, Yang G. Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis. Oncotarget 2017;8:98394-404. [PMID: 29228698 DOI: 10.18632/oncotarget.21844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
253 Bouleftour W, Granito RN, Vanden-Bossche A, Sabido O, Roche B, Thomas M, Linossier MT, Aubin JE, Lafage-Proust MH, Vico L, Malaval L. Bone Shaft Revascularization After Marrow Ablation Is Dramatically Accelerated in BSP-/- Mice, Along With Faster Hematopoietic Recolonization. J Cell Physiol 2017;232:2528-37. [PMID: 27704558 DOI: 10.1002/jcp.25630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
254 Schedlbauer A, Ozdowy P, Kontaxis G, Hartl M, Bister K, Konrat R. Backbone assignment of osteopontin, a cytokine and cell attachment protein implicated in tumorigenesis. Biomol NMR Assign 2008;2:29-31. [PMID: 19636917 DOI: 10.1007/s12104-007-9076-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
255 Wang X, Chao L, Ma G, Chen L, Tian B, Zang Y, Sun J. Increased expression of osteopontin in patients with triple-negative breast cancer. Eur J Clin Invest 2008;38:438-46. [DOI: 10.1111/j.1365-2362.2008.01956.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
256 Shimizu S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y. The prognostic significance of the comprehensive complication index in patients with gastric cancer. Surg Today 2019;49:913-20. [PMID: 31147763 DOI: 10.1007/s00595-019-01828-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
257 Nourkami-Tutdibi N, Graf N, Beier R, Zemlin M, Tutdibi E. Plasma levels of osteopontin from birth to adulthood. Pediatr Blood Cancer 2020;67:e28272. [PMID: 32227460 DOI: 10.1002/pbc.28272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
258 Zhang J, Yamada O, Kida S, Matsushita Y, Hattori T. Down-regulation of osteopontin mediates a novel mechanism underlying the cytostatic activity of TGF-β. Cell Oncol (Dordr) 2016;39:119-28. [PMID: 26584547 DOI: 10.1007/s13402-015-0257-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
259 Huang J, Sheng HH, Shen T, Hu YJ, Xiao HS, Zhang Q, Zhang QH, Han ZG. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma. FEBS Lett 2006;580:3571-81. [PMID: 16750200 DOI: 10.1016/j.febslet.2006.05.032] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
260 Bershteĭn LM, Pozharisskiĭ KM, Dil'man VM. [Effect of miskleron (clofibrate) on dimethylhydrazine induction of intestinal tumors in rats]. Biull Eksp Biol Med 1980;90:350-2. [PMID: 7426739 [PMID: 7426739 DOI: 10.3389/fonc.2020.01334] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
261 Brzezicki G, Jankowski R, Blok T, Klimczak A, Szymas J, Huber J, Szukala A, Siemionow M, Nowak S. Postlaminectomy osteopontin expression and associated neurophysiological findings in rat peridural scar model. Spine (Phila Pa 1976) 2011;36:378-85. [PMID: 20838370 DOI: 10.1097/BRS.0b013e3181d12ef4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
262 Rao G, Du L, Chen Q. Osteopontin, a possible modulator of cancer stem cells and their malignant niche. Oncoimmunology 2013;2:e24169. [PMID: 23762797 DOI: 10.4161/onci.24169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
263 Lorenzen JM, Neunhöffer H, David S, Kielstein JT, Haller H, Fliser D. Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension--results from the EUTOPIA trial. Atherosclerosis 2010;209:184-8. [PMID: 19801149 DOI: 10.1016/j.atherosclerosis.2009.09.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
264 Matsue H, Kambe N, Shimada S. Murine fetal skin-derived cultured mast cells: a useful tool for discovering functions of skin mast cells. J Invest Dermatol 2009;129:1120-5. [PMID: 19242510 DOI: 10.1038/jid.2009.44] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
265 Mohammadi S, Ghaffari SH, Shaiegan M, Zarif MN, Nikbakht M, Akbari Birgani S, Alimoghadam K, Ghavamzadeh A. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Life Sciences 2016;152:190-8. [DOI: 10.1016/j.lfs.2016.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
266 Singh A, Gill G, Kaur H, Amhmed M, Jakhu H. Role of osteopontin in bone remodeling and orthodontic tooth movement: a review. Prog Orthod 2018;19:18. [PMID: 29938297 DOI: 10.1186/s40510-018-0216-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
267 Graham TR, Agrawal KC, Abdel-Mageed AB. Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells. Cancer Sci 2010;101:103-11. [PMID: 19811499 DOI: 10.1111/j.1349-7006.2009.01356.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
268 Yan CH, Lv M, Li H, Song X, Yan F, Cao S, Ren X. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection. J Cancer Res Clin Oncol 2015;141:1371-8. [PMID: 25555465 DOI: 10.1007/s00432-014-1902-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
269 Liu Y, Lei H, Zhang J, Wang J, Li K, Dong W. Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis. PLoS One 2015;10:e0135318. [PMID: 26267616 DOI: 10.1371/journal.pone.0135318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
270 Chang PL, Harkins L, Hsieh YH, Hicks P, Sappayatosok K, Yodsanga S, Swasdison S, Chambers AF, Elmets CA, Ho KJ. Osteopontin expression in normal skin and non-melanoma skin tumors. J Histochem Cytochem 2008;56:57-66. [PMID: 17938278 DOI: 10.1369/jhc.7A7325.2007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
271 Sevtekin M, Ozmen O. Immunohistochemical examination of osteopontin and sirtuin-1 expression in cattle tuberculosis. Biotech Histochem 2018;93:405-10. [PMID: 29701069 DOI: 10.1080/10520295.2018.1443348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
272 Nazarizadeh A, Alizadeh-Fanalou S, Hosseini A, Mirzaei A, Salimi V, Keshipour H, Safizadeh B, Jamshidi K, Bahrabadi M, Tavakoli-Yaraki M. Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors. J Bone Oncol 2021;29:100377. [PMID: 34235049 DOI: 10.1016/j.jbo.2021.100377] [Reference Citation Analysis]
273 Lamour V, Le Mercier M, Lefranc F, Hagedorn M, Javerzat S, Bikfalvi A, Kiss R, Castronovo V, Bellahcène A. Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model. Int J Cancer 2010;126:1797-805. [PMID: 19609945 DOI: 10.1002/ijc.24751] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
274 Cabia B, Andrade S, Carreira MC, Casanueva FF, Crujeiras AB. A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis. Obes Rev 2016;17:361-76. [PMID: 26914773 DOI: 10.1111/obr.12377] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
275 Kang KH. Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics. J Korean Surg Soc 2013;84:9-17. [PMID: 23323230 DOI: 10.4174/jkss.2013.84.1.9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
276 Abo El-asrar M, Ismail EAR, Thabet RA, Kamel AS, Nehmedallah S. Osteopontin as a marker of vasculopathy in pediatric patients with type 1 diabetes mellitus: Relation to vascular structure. Pediatr Diabetes 2018;19:1107-15. [DOI: 10.1111/pedi.12686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
277 Hu S, Liang X, Ren X, Shi Y, Su H, Li Y, Du K, Wang J, Jia X, Chen S, Lai S. Integrated Analysis of mRNA and miRNA Expression Profiles in the Ovary of Oryctolagus cuniculus in Response to Gonadotrophic Stimulation. Front Endocrinol (Lausanne) 2019;10:744. [PMID: 31736880 DOI: 10.3389/fendo.2019.00744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
278 Kaur G, Sharma P, Dogra N, Singh S. Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges. Curr Treat Options in Oncol 2018;19. [DOI: 10.1007/s11864-018-0533-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
279 Luan M, Shi M, Pan W, Li N, Tang B. A gold-selenium-bonded nanoprobe for real-time in situ imaging of the upstream and downstream relationship between uPA and MMP-9 in cancer cells. Chem Commun (Camb) 2019;55:5817-20. [PMID: 31041939 DOI: 10.1039/c9cc01454c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
280 Dai J, Li B, Shi J, Peng L, Zhang D, Qian W, Hou S, Zhao L, Gao J, Cao Z. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunol Immunother. 2010;59:355-366. [PMID: 19690854 DOI: 10.1007/s00262-009-0754-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
281 Jin F, Jiang K, Ji S, Wang L, Ni Z, Huang F, Li C, Chen R, Zhang H, Hu Z, Zha X. Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex. Hum Mol Genet 2017;26:407-19. [PMID: 28013293 DOI: 10.1093/hmg/ddw397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
282 Lu DY, Yeh WL, Huang SM, Tang CH, Lin HY, Chou SJ. Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro Oncol 2012;14:1367-78. [PMID: 23074199 DOI: 10.1093/neuonc/nos262] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
283 Pérez-Hernández AI, Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) 2014;5:65. [PMID: 24829560 DOI: 10.3389/fendo.2014.00065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 47] [Article Influence: 2.5] [Reference Citation Analysis]
284 Chen S, Boda SK, Batra SK, Li X, Xie J. Emerging Roles of Electrospun Nanofibers in Cancer Research. Adv Healthc Mater 2018;7:e1701024. [PMID: 29210522 DOI: 10.1002/adhm.201701024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
285 Prat O, Ansoborlo E, Sage N, Cavadore D, Lecoix J, Kurttio P, Quemeneur E. From cell to man: Evaluation of osteopontin as a possible biomarker of uranium exposure. Environment International 2011;37:657-62. [DOI: 10.1016/j.envint.2011.01.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
286 He J, Zeng C, Long Y. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma. Comput Math Methods Med 2021;2021:2191709. [PMID: 34497663 DOI: 10.1155/2021/2191709] [Reference Citation Analysis]
287 Elbaiomy MA, Akl T, Elhelaly R, El-Beshbishi W, El Ghonemy MS, Elzehery R. Osteopontin level and promoter polymorphism in patients with metastatic breast cancer. Curr Oncol 2020;27:e444-50. [PMID: 33173383 DOI: 10.3747/co.27.6449] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
288 Huang J, Diaz-Meco MT, Moscat J. The macroenviromental control of cancer metabolism by p62. Cell Cycle 2018;17:2110-21. [PMID: 30198373 DOI: 10.1080/15384101.2018.1520566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
289 Butera G, Pacchiana R, Donadelli M. Autocrine mechanisms of cancer chemoresistance. Semin Cell Dev Biol 2018;78:3-12. [PMID: 28751251 DOI: 10.1016/j.semcdb.2017.07.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
290 Legg KM, Powell R, Reisdorph N, Reisdorph R, Danielson PB. Discovery of highly specific protein markers for the identification of biological stains: Proteomics and 2DE. ELECTROPHORESIS 2014;35:3069-78. [DOI: 10.1002/elps.201400125] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
291 Anwar A, Li M, Frid MG, Kumar B, Gerasimovskaya EV, Riddle SR, McKeon BA, Thukaram R, Meyrick BO, Fini MA, Stenmark KR. Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2012;303:L1-L11. [PMID: 22582113 DOI: 10.1152/ajplung.00050.2012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
292 Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal. 2011;5:111-122. [PMID: 21516514 DOI: 10.1007/s12079-011-0130-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 7.1] [Reference Citation Analysis]
293 Bulfone-Paus S, Paus R. Osteopontin as a new player in mast cell biology. Eur J Immunol 2008;38:338-41. [PMID: 18228246 DOI: 10.1002/eji.200738131] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
294 Hsieh J, Lu C, Huang C, Shieh G, Su B, Su Y, Lee C, Chang M, Wu C, Shiau A. Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment. Cancer Letters 2012;321:36-44. [DOI: 10.1016/j.canlet.2012.03.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
295 Hu J, Li G, Zhang P, Zhuang X, Hu G. A CD44v+ subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity. Cell Death Dis. 2017;8:e2679. [PMID: 28300837 DOI: 10.1038/cddis.2017.72] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
296 Karpinsky G, Fatyga A, Krawczyk MA, Chamera M, Sande N, Szmyd D, Izycka-swieszewska E, Bien E. Osteopontin: its potential role in cancer of children and young adults. Biomarkers in Medicine 2017;11:389-402. [DOI: 10.2217/bmm-2016-0308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
297 Kale S, Raja R, Thorat D, Soundararajan G, Patil TV, Kundu GC. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Oncogene 2014;33:2295-306. [PMID: 23728342 DOI: 10.1038/onc.2013.184] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
298 Zhang W, Zhao J, Lee JF, Gartung A, Jawadi H, Lambiv WL, Honn KV, Lee MJ. ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis. J Biol Chem 2013;288:32126-37. [PMID: 24064218 DOI: 10.1074/jbc.M113.495218] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
299 Schuindt SHS, Oliveira BCDL, Pimentel PMDO, Resende TL, Retamal CA, Damatta RA, Seipel D, Arnholdt ACV. Secretion of multi-protein migratory complex induced by Toxoplasma gondii infection in macrophages involves the uPA/uPAR activation system. Veterinary Parasitology 2012;186:207-15. [DOI: 10.1016/j.vetpar.2011.11.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
300 Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225-39. [DOI: 10.1007/s10555-007-9055-1] [Cited by in Crossref: 1406] [Cited by in F6Publishing: 1294] [Article Influence: 93.7] [Reference Citation Analysis]
301 Ock CY, Nam AR, Bang JH, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer. Gastric Cancer. 2015; Epub ahead of print. [PMID: 26681196 DOI: 10.1007/s10120-015-0583-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
302 Zhang W, Cui Y, Gao J, Li R, Jiang X, Tian Y, Wang K, Cui J. Recombinant Osteopontin Improves Neurological Functional Recovery and Protects Against Apoptosis via PI3K/Akt/GSK-3β Pathway Following Intracerebral Hemorrhage. Med Sci Monit 2018;24:1588-96. [PMID: 29550832 DOI: 10.12659/msm.905700] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
303 Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 2007;3:e65. [PMID: 17500590 DOI: 10.1371/journal.ppat.0030065] [Cited by in Crossref: 220] [Cited by in F6Publishing: 219] [Article Influence: 14.7] [Reference Citation Analysis]
304 Ishizuka EK, Ferreira MJ, Grund LZ, Coutinho EMM, Komegae EN, Cassado AA, Bortoluci KR, Lopes-ferreira M, Lima C. Role of interplay between IL-4 and IFN-γ in the in regulating M1 macrophage polarization induced by Nattectin. International Immunopharmacology 2012;14:513-22. [DOI: 10.1016/j.intimp.2012.08.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
305 Butti R, Gunasekaran VP, Kumar TVS, Banerjee P, Kundu GC. Breast cancer stem cells: Biology and therapeutic implications. Int J Biochem Cell Biol 2019;107:38-52. [PMID: 30529656 DOI: 10.1016/j.biocel.2018.12.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
306 Morrow KA, Das S, Meng E, Menezes ME, Bailey SK, Metge BJ, Buchsbaum DJ, Samant RS, Shevde LA. Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer. Oncotarget 2016;7:17991-8005. [PMID: 26908451 DOI: 10.18632/oncotarget.7494] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
307 Caruso DJ, Carmack AJ, Lokeshwar VB, Duncan RC, Soloway MS, Lokeshwar BL. Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clin Cancer Res. 2008;14:4111-4118. [PMID: 18593988 DOI: 10.1158/1078-0432.CCR-08-0738] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
308 Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Silva C, Rotellar F, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) 2009;87:803-13. [PMID: 19466389 DOI: 10.1007/s00109-009-0486-8] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 9.8] [Reference Citation Analysis]
309 Yuan Y, Zhang X, Weng S, Guan W, Xiang D, Gao J, Li J, Han W, Yu Y. Expression and purification of bioactive high-purity recombinant mouse SPP1 in Escherichia coli. Appl Biochem Biotechnol 2014;173:421-32. [PMID: 24664233 DOI: 10.1007/s12010-014-0849-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
310 Cortez E, Stumbo AC, Saldanha-gama R, Villela CG, Barja-fidalgo C, Rodrigues CA, das Graças Henriques M, Benchimol M, Barbosa HS, Porto LC, Carvalho L. Immunolocalization of an osteopontin-like protein in dense granules of Toxoplasma gondii tachyzoites and its association with the parasitophorous vacuole. Micron 2008;39:25-31. [DOI: 10.1016/j.micron.2007.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
311 Zheng Y, Tian C, Meng Y, Qin Y, Du Y, Du J, Li H. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J Cell Physiol 2012;227:127-35. [DOI: 10.1002/jcp.22709] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 8.4] [Reference Citation Analysis]
312 Chen RX, Xia YH, Xue TC, Ye SL. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression. Mol Biol Rep 2011;38:3671-7. [PMID: 21104439 DOI: 10.1007/s11033-010-0481-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
313 Du M, Wang X, Yuan L, Liu B, Mao X, Huang D, Yang L, Huang K, Zhang F, Wang Y, Luo X, Wang C, Peng J, Liang M, Huang D, Huang K. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology 2020;73:1333-46. [DOI: 10.1016/j.jhep.2020.07.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
314 Sarosiek K, Jones E, Chipitsyna G, Al-zoubi M, Kang C, Saxena S, Gandhi AV, Sendiky J, Yeo CJ, Arafat HA. Osteopontin (OPN) Isoforms, Diabetes, Obesity, and Cancer; What Is One Got to Do with the Other? A New Role for OPN. J Gastrointest Surg 2015;19:639-50. [DOI: 10.1007/s11605-014-2735-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
315 Huang H, Shangguan J, Ruan P, Liang H. Bi-level feature selection in high dimensional AFT models with applications to a genomic study. Stat Appl Genet Mol Biol 2019;18:/j/sagmb. [PMID: 31525158 DOI: 10.1515/sagmb-2019-0016] [Reference Citation Analysis]
316 Visser R, Rico-Llanos GA, Pulkkinen H, Becerra J. Peptides for bone tissue engineering. J Control Release 2016;244:122-35. [PMID: 27794492 DOI: 10.1016/j.jconrel.2016.10.024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
317 Sawyer AJ, Kyriakides TR. Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev 2016;97:56-68. [PMID: 26763408 DOI: 10.1016/j.addr.2015.12.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
318 Jin Y, Chen JN, Feng ZY, Zhang ZG, Fan WZ, Wang Y, Li JP. OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma. PLoS One. 2014;9:e87930. [PMID: 24498405 DOI: 10.1371/journal.pone.0087930] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
319 Li H, Shen H, Yan G, Zhang Y, Liu M, Fang P, Yu H, Yang P. Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin. Biochim Biophys Acta 2015;1854:581-91. [PMID: 25450502 DOI: 10.1016/j.bbapap.2014.09.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
320 Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochem Int 2009;55:826-32. [PMID: 19686792 DOI: 10.1016/j.neuint.2009.08.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
321 Mitra A, Conway C, Walker C, Cook M, Powell B, Lobo S, Chan M, Kissin M, Layer G, Smallwood J, Ottensmeier C, Stanley P, Peach H, Chong H, Elliott F, Iles MM, Nsengimana J, Barrett JH, Bishop DT, Newton-Bishop JA. Melanoma sentinel node biopsy and prediction models for relapse and overall survival. Br J Cancer 2010;103:1229-36. [PMID: 20859289 DOI: 10.1038/sj.bjc.6605849] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
322 Gu X, Gao XS, Ma M, Qin S, Qi X, Li X, Sun S, Yu H, Wang W, Zhou D. Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis. Oncotarget 2016;7:69666-73. [PMID: 27626167 DOI: 10.18632/oncotarget.11936] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
323 Yun S, Lee D, Kang S, Kim DW, Kim Y, Cho JY, Seo K. Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs. Vet Ophthalmol 2021;24:520-32. [PMID: 34558166 DOI: 10.1111/vop.12937] [Reference Citation Analysis]
324 Cho H, Hong SW, Oh YJ, A Kim M, Kang ES, Lee JM, Kim SW, Kim SH, Kim JH, Kim YT, Lee K. Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 2008;134:909-17. [DOI: 10.1007/s00432-007-0351-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
325 Kruger TE, Miller AH, Godwin AK, Wang J. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. Crit Rev Oncol Hematol. 2014;89:330-341. [PMID: 24071501 DOI: 10.1016/j.critrevonc.2013.08.013] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 7.3] [Reference Citation Analysis]
326 Lopez-guerrero AM, Pascual-caro C, Martin-romero FJ, Pozo-guisado E. Store-operated calcium entry is dispensable for the activation of ERK1/2 pathway in prostate cancer cells. Cellular Signalling 2017;40:44-52. [DOI: 10.1016/j.cellsig.2017.08.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
327 Chen L, Liu L, Li X, Yu Q, Yu B, Hong Y, Zheng J, Xue Y, Liu Y. RETRACTED ARTICLE: Prognostic Significance of Osteopontin and Carbonic Anhydrase 9 in Human Brain Tumors: A Meta-Analysis. Mol Neurobiol 2015;52:1884-1884. [DOI: 10.1007/s12035-014-8904-5] [Reference Citation Analysis]
328 Yushi Q, Li Z, Von Roemeling CA, Doeppler H, Marlow LA, Kim BY, Radisky DC, Storz P, Copland JA, Tun HW. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. Oncotarget 2016;7:32156-71. [PMID: 27050077 DOI: 10.18632/oncotarget.8537] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
329 Cao DX, Li ZJ, Jiang XO, Lum YL, Khin E, Lee NP, Wu GH, Luk JM. Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol 2012; 18(30): 3923-3930 [PMID: 22912540 DOI: 10.3748/wjg.v18.i30.3923] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
330 Lee JL, Wang MJ, Sudhir PR, Chen JY. CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Mol Cell Biol 2008;28:5710-23. [PMID: 18644869 DOI: 10.1128/MCB.00186-08] [Cited by in Crossref: 69] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
331 Lu C, Fang S, Weng Q, Lv X, Meng M, Zhu J, Zheng L, Hu Y, Gao Y, Wu X, Mao J, Tang B, Zhao Z, Huang L, Ji J. Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma. Cell Commun Signal 2020;18:97. [PMID: 32576292 DOI: 10.1186/s12964-020-00539-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
332 Ji HI, Lee SH, Song R, Yang HI, Lee YA, Hong SJ, Kim S, Park YB, Lee SK, Yoo MC, Kim KS. Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis. Clin Rheumatol 2014;33:397-402. [PMID: 23995733 DOI: 10.1007/s10067-013-2375-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
333 Kurzbach D, Beier A, Vanas A, Flamm AG, Platzer G, Schwarz TC, Konrat R. NMR probing and visualization of correlated structural fluctuations in intrinsically disordered proteins. Phys Chem Chem Phys 2017;19:10651-6. [PMID: 28397898 DOI: 10.1039/c7cp00430c] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
334 Karunakaran M, Devanathan TG. Evaluation of bull semen for fertility-associated protein, in vitro characters and fertility. Journal of Applied Animal Research 2017;45:136-44. [DOI: 10.1080/09712119.2015.1129343] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
335 Geng S, Wang Q, Wang J, Hu Z, Liu C, Qiu J, Zeng W. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431. Arch Dermatol Res 2011;303:181-9. [PMID: 21240514 DOI: 10.1007/s00403-010-1100-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
336 Ishii M, Arias AC, Liu L, Chen YB, Bronner ME, Maxson RE. A stable cranial neural crest cell line from mouse. Stem Cells Dev 2012;21:3069-80. [PMID: 22889333 DOI: 10.1089/scd.2012.0155] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
337 Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441:1075-1079. [PMID: 16810242 DOI: 10.1038/nature04957] [Cited by in Crossref: 1271] [Cited by in F6Publishing: 1151] [Article Influence: 79.4] [Reference Citation Analysis]
338 Souza CEA, Moura AA, Monaco E, Killian GJ. Binding patterns of bovine seminal plasma proteins A1/A2, 30kDa and osteopontin on ejaculated sperm before and after incubation with isthmic and ampullary oviductal fluid. Animal Reproduction Science 2008;105:72-89. [DOI: 10.1016/j.anireprosci.2007.11.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
339 Haller F, Zhang JD, Moskalev EA, Braun A, Otto C, Geddert H, Riazalhosseini Y, Ward A, Balwierz A, Schaefer I, Cameron S, Ghadimi BM, Agaimy A, Fletcher JA, Hoheisel J, Hartmann A, Werner M, Wiemann S, Sahin Ö. Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of SPP1 as an independent prognostic factor: SPP1 in GIST. Int J Cancer 2015;136:1013-23. [DOI: 10.1002/ijc.29088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
340 Luo X, Ruhland MK, Pazolli E, Lind AC, Stewart SA. Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Mol Cancer Res 2011;9:1018-29. [PMID: 21673011 DOI: 10.1158/1541-7786.MCR-10-0472] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
341 Zhao F, Zhang Y, Wang H, Jin M, He S, Shi Y, Guo Y, Zhang Y. Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease. Blood 2011;117:1723-33. [PMID: 21119110 DOI: 10.1182/blood-2010-04-281659] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
342 Jiang R, Lönnerdal B. Osteopontin in human milk and infant formula affects infant plasma osteopontin concentrations. Pediatr Res 2019;85:502-5. [PMID: 30636771 DOI: 10.1038/s41390-018-0271-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
343 Dai N, Bao Q, Lu A, Li J. Protein Expression of Osteopontin in Tumor Tissues Is an Independent Prognostic Indicator in Gastric Cancer. Oncology 2007;72:89-96. [DOI: 10.1159/000111108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
344 Zhou Y, Romson J, Emmer Å. An antibody-free sample pretreatment method for osteopontin combined with MALDI-TOF MS/MS analysis. PLoS One 2019;14:e0213405. [PMID: 30845167 DOI: 10.1371/journal.pone.0213405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
345 Buback F, Renkl AC, Schulz G, Weiss JM. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol 2009;18:750-9. [PMID: 19558497 DOI: 10.1111/j.1600-0625.2009.00926.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
346 Allan MF, Thallman RM, Cushman RA, Echternkamp SE, White SN, Kuehn LA, Casas E, Smith TP. Association of a single nucleotide polymorphism in SPP1 with growth traits and twinning in a cattle population selected for twinning rate. J Anim Sci 2007;85:341-7. [PMID: 17040953 DOI: 10.2527/jas.2006-460] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
347 Liu SJ, Zhang DQ, Sui XM, Zhang L, Cai ZW, Sun LQ, Liu YJ, Xue Y, Hu GF. The inhibition of in vivo tumorigenesis of osteosarcoma (OS)-732 cells by antisense human osteopontin RNA. Cell Mol Biol Lett 2008;13:11-9. [PMID: 17952379 DOI: 10.2478/s11658-007-0031-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
348 Shima H, Yamada A, Ishikawa T, Endo I. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy? Gland Surg 2017;6:82-8. [PMID: 28210556 DOI: 10.21037/gs.2016.08.03] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
349 Hsu KH, Tsai HW, Lin PW, Hsu YS, Lu PJ, Shan YS. Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors. World J Surg Oncol 2014;12:189. [PMID: 24947165 DOI: 10.1186/1477-7819-12-189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
350 Wang Y, Liu B. Expression of osteopontin and its receptors in ameloblastomas. Oral Oncology 2009;45:538-42. [DOI: 10.1016/j.oraloncology.2008.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
351 Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem. 2009;107:1053-1062. [PMID: 19479945 DOI: 10.1002/jcb.22214] [Cited by in Crossref: 283] [Cited by in F6Publishing: 250] [Article Influence: 21.8] [Reference Citation Analysis]
352 Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Silva C, Rotellar F, Hernández-Lizoain JL, Baixauli J, Valentí V, Pardo F, Salvador J, Frühbeck G. Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J Nutr Biochem 2011;22:634-41. [PMID: 20961744 DOI: 10.1016/j.jnutbio.2010.04.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
353 Bjørndal K, Larsen SR, Godballe C, Krogdahl A. Osteopontin expression in salivary gland carcinomas: Osteopontin expression in salivary gland carcinomas. Journal of Oral Pathology & Medicine 2011;40:451-5. [DOI: 10.1111/j.1600-0714.2010.00964.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
354 Maeda N, Ohashi T, Chagan-Yasutan H, Hattori T, Takahashi Y, Harigae H, Hasegawa H, Yamada Y, Fujii M, Maenaka K, Uede T. Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia. Retrovirology 2015;12:99. [PMID: 26597716 DOI: 10.1186/s12977-015-0225-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
355 Ramankulov A, Lein M, Kristiansen G, Loening SA, Jung K. Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer. Prostate 2007;67:330-40. [DOI: 10.1002/pros.20540] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
356 Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, Dear AE, Palmer LJ, Norman PE. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2007;27:655-60. [PMID: 17170369 DOI: 10.1161/01.ATV.0000255560.49503.4e] [Cited by in Crossref: 94] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
357 Psallidas I, Stathopoulos GT, Maniatis NA, Magkouta S, Moschos C, Karabela SP, Kollintza A, Simoes DC, Kardara M, Vassiliou S, Papiris SA, Roussos C, Kalomenidis I. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene 2013;32:528-35. [PMID: 22370646 DOI: 10.1038/onc.2012.57] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
358 Moon EJ, Brizel DM, Chi JT, Dewhirst MW. The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 2007;9:1237-94. [PMID: 17571959 DOI: 10.1089/ars.2007.1623] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
359 Shen CJ, Tsou YA, Chen HL, Huang HJ, Wu SC, Cheng WT, Chen CY, Chen CM. Osteoponin promoter controlled by DNA methylation: aberrant methylation in cloned porcine genome. Biomed Res Int 2014;2014:327538. [PMID: 25101273 DOI: 10.1155/2014/327538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
360 Zhang J, Yang G, Zhu Y, Peng X, Li T, Liu L. Relationship of Cx43 regulation of vascular permeability to osteopontin-tight junction protein pathway after sepsis in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2018;314:R1-R11. [DOI: 10.1152/ajpregu.00443.2016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
361 Mierke CT. The biomechanical properties of 3d extracellular matrices and embedded cells regulate the invasiveness of cancer cells. Cell Biochem Biophys 2011;61:217-36. [PMID: 21516307 DOI: 10.1007/s12013-011-9193-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
362 Guarneri C, Bevelacqua V, Polesel J, Falzone L, Cannavò PS, Spandidos DA, Malaponte G, Libra M. NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma. Oncol Rep 2017;37:737-46. [PMID: 28075446 DOI: 10.3892/or.2017.5362] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
363 Bommi PV, Bowen CM, Reyes-Uribe L, Wu W, Katayama H, Rocha P, Parra ER, Francisco-Cruz A, Ozcan Z, Tosti E, Willis JA, Wu H, Taggart MW, Burks JK, Lynch PM, Edelmann W, Scheet PA, Wistuba II, Sinha KM, Hanash SM, Vilar E. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells. Cancer Res 2021;81:2760-73. [PMID: 34003775 DOI: 10.1158/0008-5472.CAN-20-2896] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
364 Chiu YW, Tu HF, Wang IK, Wu CH, Chang KW, Liu TY, Kao SY. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol 2010;46:302-6. [PMID: 20219412 DOI: 10.1016/j.oraloncology.2010.01.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
365 Madoz-Gúrpide J, López-Serra P, Martínez-Torrecuadrada JL, Sánchez L, Lombardía L, Casal JI. Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. Mol Cell Proteomics. 2006;5:1471-1483. [PMID: 16733264 DOI: 10.1074/mcp.m600048-mcp200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
366 Park MG, Oh MM, Yoon JH, Park JY, Park HS, Moon DG, Yoon DK. The value of plasma osteopontin levels as a predictive factor of disease stage and recurrence in patients with bladder urothelial carcinoma: a prospective study. Kaohsiung J Med Sci 2012;28:526-30. [PMID: 23089317 DOI: 10.1016/j.kjms.2012.04.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
367 Thakur R, Mishra DP. Matrix reloaded: CCN, tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities. Pharmacology & Therapeutics 2016;168:61-74. [DOI: 10.1016/j.pharmthera.2016.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
368 Li H, Li H, Huo R, Wu P, Shen Z, Xu H, Shen B, Li N. Cyr61/CCN1 induces CCL20 production by keratinocyte via activating p38 and JNK/AP-1 pathway in psoriasis. Journal of Dermatological Science 2017;88:46-56. [DOI: 10.1016/j.jdermsci.2017.05.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
369 Chakraborty D, Viveka TS, Arvind K, Shyamsundar V, Kanchan M, Alex SA, Chandrasekaran N, Vijayalakshmi R, Mukherjee A. A facile gold nanoparticle–based ELISA system for detection of osteopontin in saliva: Towards oral cancer diagnostics. Clinica Chimica Acta 2018;477:166-72. [DOI: 10.1016/j.cca.2017.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
370 Lorenzen JM, Schauerte C, Hübner A, Kölling M, Martino F, Scherf K, Batkai S, Zimmer K, Foinquinos A, Kaucsar T, Fiedler J, Kumarswamy R, Bang C, Hartmann D, Gupta SK, Kielstein J, Jungmann A, Katus HA, Weidemann F, Müller OJ, Haller H, Thum T. Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis. Eur Heart J 2015;36:2184-96. [PMID: 25898844 DOI: 10.1093/eurheartj/ehv109] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 12.4] [Reference Citation Analysis]
371 Fukunaga-Kalabis M, Santiago-Walker A, Herlyn M. Matricellular proteins produced by melanocytes and melanomas: in search for functions. Cancer Microenviron 2008;1:93-102. [PMID: 19308688 DOI: 10.1007/s12307-008-0009-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
372 Schultz J, Lorenz P, Ibrahim SM, Kundt G, Gross G, Kunz M. The functional −443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor. Mol Carcinog 2009;48:14-23. [DOI: 10.1002/mc.20452] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
373 Feng J, Zhou J, Zhao L, Wang X, Ma D, Xu B, Xie F, Qi X, Chen G, Zhao H, Wu J. Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma. Front Genet 2021;12:757014. [PMID: 34970298 DOI: 10.3389/fgene.2021.757014] [Reference Citation Analysis]
374 Tai S, Hu XQ, Peng DQ, Zhou SH, Zheng XL. The roles of autophagy in vascular smooth muscle cells. Int J Cardiol 2016;211:1-6. [PMID: 26954728 DOI: 10.1016/j.ijcard.2016.02.128] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
375 La Y, Zhang X, Li F, Zhang D, Li C, Mo F, Wang W. Molecular Characterization and Expression of SPP1, LAP3 and LCORL and Their Association with Growth Traits in Sheep. Genes (Basel) 2019;10:E616. [PMID: 31416156 DOI: 10.3390/genes10080616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
376 Goel S, Sahu S, Minz RW, Singh S, Suri D, Oh YM, Rawat A, Sehgal S, Saikia B. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome. Front Immunol 2018;9:1080. [PMID: 29868029 DOI: 10.3389/fimmu.2018.01080] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
377 Shan M, Yuan X, Song LZ, Roberts L, Zarinkamar N, Seryshev A, Zhang Y, Hilsenbeck S, Chang SH, Dong C, Corry DB, Kheradmand F. Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema. Sci Transl Med 2012;4:117ra9. [PMID: 22261033 DOI: 10.1126/scitranslmed.3003041] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 10.2] [Reference Citation Analysis]
378 Hamilton SL, Ferando B, Eapen AS, Yu JC, Joy AR. Cancer Secretome May Influence BSP and DSP Expression in Human Salivary Gland Cells. J Histochem Cytochem 2017;65:139-51. [PMID: 27881474 DOI: 10.1369/0022155416676064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
379 Ortiz-martínez F, Sanmartín E, Pomares-navarro E, Pérez-balaguer A, Andrés L, Sánchez-payá J, Aranda FI, Lerma E, Peiró G. Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma. American Journal of Clinical Pathology 2015;143:812-22. [DOI: 10.1309/ajcp6f2vndamsula] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
380 Hernández-Camarero P, López-Ruiz E, Griñán-Lisón C, García MÁ, Chocarro-Wrona C, Marchal JA, Kenyon J, Perán M. Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting. Sci Rep 2019;9:11359. [PMID: 31388092 DOI: 10.1038/s41598-019-47837-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
381 Im E, Yeo C, Lee E. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells. Life Sciences 2018;209:259-66. [DOI: 10.1016/j.lfs.2018.08.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
382 Sun BS, Li Y, Zhang ZF, You J, Wang CL. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection. Ann Thorac Surg 2013;96:1943-51. [PMID: 24094519 DOI: 10.1016/j.athoracsur.2013.07.089] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
383 Lin J, Lu M, Shao WQ, Chen ZY, Zhu WW, Lu L, Jia HL, Cai D, Qin LX, Chen JH. Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation. Sci Rep 2016;6:30215. [PMID: 27484115 DOI: 10.1038/srep30215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
384 Ogata T, Ueyama T, Nomura T, Asada S, Tagawa M, Nakamura T, Takahashi T, Matsubara H, Oh H. Osteopontin is a myosphere-derived secretory molecule that promotes angiogenic progenitor cell proliferation through the phosphoinositide 3-kinase/Akt pathway. Biochemical and Biophysical Research Communications 2007;359:341-7. [DOI: 10.1016/j.bbrc.2007.05.104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
385 Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 2010;31:192-200. [DOI: 10.1093/carcin/bgp289] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
386 Song X, Yang C, Zhang H, Wang J, Sun X, Hu L, Liu Z, Wang D. Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis. Ann Otol Rhinol Laryngol 2018;127:357-66. [PMID: 29717655 DOI: 10.1177/0003489418765563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
387 Hodgin JB, Borczuk AC, Nasr SH, Markowitz GS, Nair V, Martini S, Eichinger F, Vining C, Berthier CC, Kretzler M. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol. 2010;177:1674-1686. [PMID: 20847290 DOI: 10.2353/ajpath.2010.090746] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 6.3] [Reference Citation Analysis]
388 Shirasaki T, Honda M, Yamashita T, Nio K, Shimakami T, Shimizu R, Nakasyo S, Murai K, Shirasaki N, Okada H, Sakai Y, Sato T, Suzuki T, Yoshioka K, Kaneko S. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication. Sci Rep 2018;8:13143. [PMID: 30177680 DOI: 10.1038/s41598-018-31421-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
389 Raja R, Kale S, Thorat D, Soundararajan G, Lohite K, Mane A, Karnik S, Kundu GC. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Oncogene. 2014;33:2053-2064. [PMID: 23728336 DOI: 10.1038/onc.2013.171] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
390 Al-Rawaf HA, Alghadir AH, Gabr SA. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study. Biomed Res Int 2021;2021:7453000. [PMID: 34917685 DOI: 10.1155/2021/7453000] [Reference Citation Analysis]
391 Barranco G, Fernández E, Rivas S, Quezada R, Nava D, Aguilar J, García A, Astudillo H, Lome C, Ruiz E. Osteopontin expression and its relationship with prognostic factors in diffuse large B-cell lymphoma. Hematol Rep 2019;11:7964. [PMID: 31579151 DOI: 10.4081/hr.2019.7964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
392 Lorenzen J, Shah R, Biser A, Staicu SA, Niranjan T, Garcia AM, Gruenwald A, Thomas DB, Shatat IF, Supe K. The role of osteopontin in the development of albuminuria. J Am Soc Nephrol. 2008;19:884-890. [PMID: 18443355 DOI: 10.1681/asn.2007040486] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
393 Masoumi J, Jafarzadeh A, Khorramdelazad H, Abbasloui M, Abdolalizadeh J, Jamali N. Role of Apelin/APJ axis in cancer development and progression. Adv Med Sci 2020;65:202-13. [PMID: 32087570 DOI: 10.1016/j.advms.2020.02.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
394 Tunaitis V, Borutinskaitė V, Navakauskienė R, Treigytė G, Ungurytė A, Aldonytė R, Magnusson KE, Pivoriūnas A. Effects of different sera on adipose tissue-derived mesenchymal stromal cells. J Tissue Eng Regen Med 2011;5:733-46. [PMID: 21953871 DOI: 10.1002/term.374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
395 Zou XL, Wang C, Liu KE, Nie W, Ding ZY. Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis. Mol Clin Oncol 2015;3:633-8. [PMID: 26137280 DOI: 10.3892/mco.2015.517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
396 Nakamura KD, Tilli TM, Wanderley JL, Palumbo A Jr, Mattos RM, Ferreira AC, Klumb CE, Nasciutti LE, Gimba ER. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells. Tumour Biol 2016;37:2655-63. [PMID: 26404131 DOI: 10.1007/s13277-015-4095-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
397 Bozorgi A, Khazaei M, Khazaei MR. New Findings on Breast Cancer Stem Cells: A Review. J Breast Cancer 2015;18:303-12. [PMID: 26770236 DOI: 10.4048/jbc.2015.18.4.303] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 10.3] [Reference Citation Analysis]
398 Mannello F, Tonti GA, Medda V, Simone P, Darbre PD. Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients: Aluminium and iron homeostasis in NAF. J Appl Toxicol 2011;31:262-9. [DOI: 10.1002/jat.1641] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
399 Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 2008;19:333-345. [PMID: 18952487 DOI: 10.1016/j.cytogfr.2008.08.001] [Cited by in Crossref: 439] [Cited by in F6Publishing: 424] [Article Influence: 31.4] [Reference Citation Analysis]
400 Starr JS, Jiang L, Li Z, Qiu Y, Menke DM, Tun HW. CD47 and osteopontin expression in diffuse large B-cell lymphoma with nodal and intravascular involvement. Clin Lymphoma Myeloma Leuk 2013;13:597-601. [PMID: 23810243 DOI: 10.1016/j.clml.2013.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
401 Chan CH, Wong P. Molecular Predictors of Radiotherapy Response in Sarcoma. Curr Treat Options Oncol 2016;17:2. [PMID: 26714494 DOI: 10.1007/s11864-015-0381-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
402 Conway C, Mitra A, Jewell R, Randerson-Moor J, Lobo S, Nsengimana J, Edward S, Sanders DS, Cook M, Powell B, Boon A, Elliott F, de Kort F, Knowles MA, Bishop DT, Newton-Bishop J. Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival. Clin Cancer Res 2009;15:6939-46. [PMID: 19887478 DOI: 10.1158/1078-0432.CCR-09-1631] [Cited by in Crossref: 80] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
403 Nallasamy P, Nimmakayala RK, Karmakar S, Leon F, Seshacharyulu P, Lakshmanan I, Rachagani S, Mallya K, Zhang C, Ly QP, Myers MS, Josh L, Grabow CE, Gautam SK, Kumar S, Lele SM, Jain M, Batra SK, Ponnusamy MP. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis. Gastroenterology 2021:S0016-5085(21)03402-8. [PMID: 34418441 DOI: 10.1053/j.gastro.2021.08.023] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
404 Songtao Q, Guanglong H, Jun P, Jia L, Xi’an Z, Luxiong F, Baoguo L, Wei M, Yongming Z, Xiaojun L. Involvement of osteopontin as a core protein in craniopharyngioma calcification formation. J Neurooncol 2010;98:21-30. [DOI: 10.1007/s11060-009-0053-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
405 Schulz A, Gorodetska I, Behrendt R, Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A, Muders MH. Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer. Front Oncol 2019;9:1461. [PMID: 32038994 DOI: 10.3389/fonc.2019.01461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
406 Wang YT, Tsai CF, Hong TC, Tsou CC, Lin PY, Pan SH, Hong TM, Yang PC, Sung TY, Hsu WL, Chen YJ. An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 2010;9:5582-97. [PMID: 20815410 DOI: 10.1021/pr100394u] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
407 Tang H, Wang J, Bai F, Hong L, Liang J, Gao J, Zhai H, Lan M, Zhang F, Wu K. Inhibition of osteopontin would suppress angiogenesis in gastric cancer. Biochem Cell Biol. 2007;85:103-110. [PMID: 17464350 DOI: 10.1139/o06-208] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
408 Valcz G, Sipos F, Krenács T, Molnár J, Patai AV, Leiszter K, Tóth K, Solymosi N, Galamb O, Molnár B, Tulassay Z. Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence. Pathol Oncol Res 2010;16:541-5. [PMID: 20349162 DOI: 10.1007/s12253-010-9260-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
409 Chen M, Myers AK, Markey MP, Long W. The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness. J Cell Physiol 2019;234:13220-32. [PMID: 30569573 DOI: 10.1002/jcp.27994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
410 Jain S, Chakraborty G, Bulbule A, Kaur R, Kundu GC. Osteopontin: an emerging therapeutic target for anticancer therapy. Expert Opin Ther Targets 2007;11:81-90. [PMID: 17150036 DOI: 10.1517/14728222.11.1.81] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
411 Chang W, Yang H, Cheng H, Chuang C, Lu P, Sheu B. Increased Gastric Osteopontin Expression by Helicobacter pylori Infection can Correlate with More Severe Gastric Inflammation and Intestinal Metaplasia: OPN in H. pylori-Related Chronic Gastritis. Helicobacter 2011;16:217-24. [DOI: 10.1111/j.1523-5378.2011.00832.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
412 Djuzenova CS, Fiedler V, Memmel S, Katzer A, Hartmann S, Krohne G, Zimmermann H, Scholz CJ, Polat B, Flentje M, Sukhorukov VL. Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status. Exp Cell Res 2015;330:346-57. [PMID: 25149900 DOI: 10.1016/j.yexcr.2014.08.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
413 Lancha A, Moncada R, Valentí V, Rodríguez A, Catalán V, Becerril S, Ramírez B, Méndez-giménez L, Frühbeck G, Gómez-ambrosi J. Effect of Sleeve Gastrectomy on Osteopontin Circulating Levels and Expression in Adipose Tissue and Liver in Rats. OBES SURG 2014;24:1702-8. [DOI: 10.1007/s11695-014-1240-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
414 Shao L, Zhang B, Wang L, Wu L, Kan Q, Fan K. MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells. Biochemical and Biophysical Research Communications 2017;493:1478-84. [DOI: 10.1016/j.bbrc.2017.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
415 Weng S, Zhou L, Han L, Yuan Y. Expression and purification of non-tagged recombinant mouse SPP1 in E. coli and its biological significance. Bioengineered 2014;5:405-8. [PMID: 25482081 DOI: 10.4161/bioe.34424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
416 Liu G, Liu G, Alzoubi K, Chatterjee M, Walker B, Münzer P, Luo D, Umbach AT, Elvira B, Chen H, Voelkl J, Föller M, Mak TW, Borst O, Gawaz M, Lang F. CD44 sensitivity of platelet activation, membrane scrambling and adhesion under high arterial shear rates. Thromb Haemost 2016;115:99-108. [PMID: 26355696 DOI: 10.1160/TH14-10-0847] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
417 Wang R, Jin Y, Yao XH, Fan W, Zhang J, Cao Y, Li J. A novel mechanism of the M1-M2 methionine adenosyltransferase switch-mediated hepatocellular carcinoma metastasis. Mol Carcinog. 2018;57:1201-1212. [PMID: 29749642 DOI: 10.1002/mc.22836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
418 Chen LZ, He CY, Su X, Peng JL, Chen DL, Ye Z, Yang DD, Wang ZX, Wang F, Shao JY, Xu RH. SPP1 rs4754 and its epistatic interactions with SPARC polymorphisms in gastric cancer susceptibility. Gene 2018;640:43-50. [PMID: 28962925 DOI: 10.1016/j.gene.2017.09.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
419 Vashisht S, Bagler G. An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene ontology analysis. PLoS One 2012;7:e49401. [PMID: 23166660 DOI: 10.1371/journal.pone.0049401] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
420 Mandelin J, Lin EC, Hu DD, Knowles SK, Do KA, Wang X, Sage EH, Smith JW, Arap W, Pasqualini R. Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin. Cancer 2009;115:1753-64. [PMID: 19224553 DOI: 10.1002/cncr.24170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
421 Kaleta B. Role of osteopontin in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz) 2014;62:475-82. [PMID: 24917428 DOI: 10.1007/s00005-014-0294-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
422 Li Y, Sun BS, Pei B, Li CG, Zhang ZF, Yin YS, Wang CL. Osteopontin-expressing macrophages in non-small cell lung cancer predict survival. Ann Thorac Surg 2015;99:1140-8. [PMID: 25725928 DOI: 10.1016/j.athoracsur.2014.11.054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
423 Min TU, Sheng LY, Chao C, Jian T, Guang GS, Hua LG. Correlation between osteopontin and caveolin-1 in the pathogenesis and progression of osteoarthritis. Exp Ther Med 2015;9:2059-64. [PMID: 26136936 DOI: 10.3892/etm.2015.2433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
424 Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem 2018;59:17-24. [PMID: 30003880 DOI: 10.1016/j.clinbiochem.2018.07.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 27.3] [Reference Citation Analysis]
425 Nishikawa M, Inoue A, Ohnishi T, Yano H, Ozaki S, Kanemura Y, Suehiro S, Ohtsuka Y, Kohno S, Ohue S, Shigekawa S, Watanabe H, Kitazawa R, Tanaka J, Kunieda T. Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma. Transl Oncol 2021;14:101137. [PMID: 34052625 DOI: 10.1016/j.tranon.2021.101137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
426 Wolak T. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease. Atherosclerosis 2014;236:327-37. [PMID: 25128758 DOI: 10.1016/j.atherosclerosis.2014.07.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 9.9] [Reference Citation Analysis]
427 Iqbal J, McRae S, Banaudha K, Mai T, Waris G. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. J Biol Chem 2013;288:36994-7009. [PMID: 24240095 DOI: 10.1074/jbc.M113.492314] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
428 Senbanjo LT, AlJohani H, Majumdar S, Chellaiah MA. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells. Cell Commun Signal 2019;17:80. [PMID: 31331331 DOI: 10.1186/s12964-019-0395-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
429 Nandy SB, Lakshmanaswamy R. Cancer Stem Cells and Metastasis. Approaches to Understanding Breast Cancer. Elsevier; 2017. pp. 137-76. [DOI: 10.1016/bs.pmbts.2017.07.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
430 Wu J, Pungaliya P, Kraynov E, Bates B. Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometry. Biomarkers 2012;17:125-33. [PMID: 22188260 DOI: 10.3109/1354750X.2011.643485] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
431 Ramankulov A, Lein M, Kristiansen G, Meyer HA, Loening SA, Jung K. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma. J Cancer Res Clin Oncol. 2007;133:643-652. [PMID: 17479289 DOI: 10.1007/s00432-007-0215-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
432 Wu B, Ma Q, Suzuki H, Chen C, Liu W, Tang J, Zhang J. Recombinant osteopontin attenuates brain injury after intracerebral hemorrhage in mice. Neurocrit Care 2011;14:109-17. [PMID: 20440599 DOI: 10.1007/s12028-010-9372-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
433 Yamamoto T, Murayama S, Takao M, Isa T, Higo N. Expression of secreted phosphoprotein 1 (osteopontin) in human sensorimotor cortex and spinal cord: Changes in patients with amyotrophic lateral sclerosis. Brain Research 2017;1655:168-75. [DOI: 10.1016/j.brainres.2016.10.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
434 Heilmann K, Hoffmann U, Witte E, Loddenkemper C, Sina C, Schreiber S, Hayford C, Holzlöhner P, Wolk K, Tchatchou E, Moos V, Zeitz M, Sabat R, Günthert U, Wittig BM. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med 2009;13:1162-74. [PMID: 18627421 DOI: 10.1111/j.1582-4934.2008.00428.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
435 Wang C, Shi Z, Zhang Y, Li M, Zhu J, Huang Z, Zhang J, Chen J. CBFβ promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner. Cell Death Differ 2021. [PMID: 34050318 DOI: 10.1038/s41418-021-00810-2] [Reference Citation Analysis]
436 Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S, Cocorullo G, Gulotta G, Dieli F, De Maria R, Stassi G. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14:342-356. [PMID: 24607406 DOI: 10.1016/j.stem.2014.01.009] [Cited by in Crossref: 421] [Cited by in F6Publishing: 404] [Article Influence: 52.6] [Reference Citation Analysis]
437 Reufsteck C, Lifshitz-Shovali R, Zepp M, Bäuerle T, Kübler D, Golomb G, Berger MR. Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions. Clin Exp Metastasis. 2012;29:441-456. [PMID: 22407340 DOI: 10.1007/s10585-012-9462-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
438 Suzuki H, Hasegawa Y, Chen W, Kanamaru K, Zhang JH. Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage. Ann Neurol 2010;68:650-60. [PMID: 21031580 DOI: 10.1002/ana.22102] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]